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TRAUMATIC BRAIN INJURY: CYCLOPHILIN D AS A THERAPEUTIC TARGET 
AND THE NEUROPATHOLOGY CAUSED BY BLAST 
 
 With an estimated incidence of 1.5 million each year, traumatic brain injury (TBI) 
is a major cause of mortality and morbidity in the United States. Opening of the 
mitochondrial permeability transition pore (mPTP) is a key event contributing to TBI 
pathology. Cyclophilin D (CypD), a matrix peptidyl-prolyl cis-trans isomerase, is 
believed to be the regulating component of the mPTP. Cyclosporin A, an 
immunosuppressant drug, inhibits CypD and blocks mPTP formation and has been shown 
to be neuroprotective following TBI. However, it is unclear if CsA’s neuroprotective 
mechanism is due to inhibition of CypD and/or immuno-suppression. Therefore to 
directly assess the contribution of CypD to TBI pathology, CypD knockout mice were 
subjected to a controlled cortical impact model of TBI. CypD ablation resulted in 
increased tissue sparing, hippocampal protection, and improved mitochondrial complex I 
driven respiration. Next a dose-response study of the Cyclophilin D inhibitor, NIM811, 
was performed. NIM811 administration following TBI resulted in improved cognition, 
increased tissue sparing, and improved mitochondrial function. These results suggest a 
major role for CypD in TBI pathology and validate CypD as a potential therapeutic target 
for TBI.   
 TBI has been proposed to be the signature injury of the current Middle Eastern 
conflicts with an estimated prevalence of 15-60 % among combat soldiers. Although the 
brain does appear to be vulnerable to blast, the exact mechanisms underlying the injury 
remain unclear. Adult male Sprague-Dawley rats were exposed to a moderate level of 
blast overpressure. Following blast, blood brain barrier disruption was evident at 3 and 24 
h post-exposure, oxidative damage increased at 3 h post-exposure, and microglia were 
activated in the hippocampus at 5 and 10 days post-exposure. This may widen future 
neuroprotective avenues for blast since blast brain injury appears to share similar 
mechanisms of injury with other TBI models.  
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1. CHAPTER 1 
Introduction and Background 
1.1 An overview of traumatic brain injury 
1.1.1 Traumatic brain injury in the US 
 In the United States, approximately 1.5 million individuals each year sustain a 
traumatic brain injury (TBI) severe enough to warrant medical attention (Corrigan et al. 
2010).  This estimate is conservative since many individuals with mild TBIs do not seek 
medical attention. Following hospitalization with TBI, as many as 3.2 million Americans 
are currently living with an injury-related disability (Corrigan et al. 2010). The high 
incidence and devastating consequences of TBI produce an enormous economic burden 
in the US with total costs in excess of $60 billion a year.  Unfortunately there are 
currently no approved pharmacological treatments for TBI and care remains aimed at 
acute clinical management and chronic rehabilitation therapy (Hatton 2001). 
 Major risk factors for civilian TBI (cTBI) are age and gender (Corrigan et al. 
2010). The incidence of cTBI is increased in the elderly and the young, with 659 and 900 
per 100,000, respectively.  Increased risk-taking behavior in males contributes to them 
being twice as likely as females to sustain a cTBI. Falls, motor vehicle accidents, 
incidents involving the head being struck by or against an object, and assaults are the 
major causes of cTBI (Fig. 1.1) (Langlois et al. 2006). Another major cause of cTBI are 
the approximately 300,000 sports-related TBIs reported yearly (Thurman et al. 1998).  
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Causes of Civilian Traumatic Brain Injury 
 
 
Figure 1.1. Causes of civilian TBI (cTBI) in the United States. Falls, at 28 %, are the 
most common cause of cTBI. The second most common cause of cTBI is motor vehicle 
accidents (20 %). Followed by other (i.e. suicide attempt, unknown, bicycle crashes) at 
22 %, struck by or against at 19 %, and violence at 11 %. (Modified from Langlois et al. 
2006) 
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 TBI is a clinically heterogeneous neurological disorder which, depending on 
injury severity, may produce symptoms ranging from a brief disruption in mental status 
to long-lasting physical and mental disability. The Glasgow Coma Scale (GCS) is the 
most widely used diagnostic tool for initial assessment of the severity of TBI (Andriessen 
et al. 2010). The GCS is scored based on an individual’s eye response, verbal response, 
and motor response. A GCS score of 13-15 represents a mild TBI, 9-12 moderate TBI, 
and a ≤8 as a severe TBI. 
1.1.2 Military TBI 
 Recent military operations in the Middle East have resulted in an increased public 
awareness of TBI. However, military TBI isn’t a new phenomena and reports of “shell 
shock” date back to World Wars I and II (WWI and WWII) (Jones et al. 2007). During 
WWI soldiers without head wounds presented with amnesia, headache, and poor 
concentration (Jones et al. 2007). Some of these soldiers had been in close proximity to a 
blast event, while others with similar symptoms had not been anywhere near an 
explosion. This observation lead a British psychologist to postulate that since soldiers are 
exposed to large amounts of stress while in combat, that some cases of shell shock are 
psychological in origin rather than the result of a brain lesion (Jones et al. 2007). Whether 
or not the neuropathological symptoms following blast exposure are the result of head  
trauma or psychological in origin continues to be debated.  
 Better battlefield technology (i.e. personal body armor) and medical care allow 
present day soldiers to survive blasts that would have been deadly in other wars. As such 
TBI has been proposed to be the signature injury of Operation Iraqi Freedom (OIF) and 
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Operation Enduring Freedom (OEF) (Elder and Cristian 2009). One recent study reported 
that approximately 15% of 2525 Army infantry soldiers surveyed had experienced either 
injuries with a loss of consciousness or injuries with altered mental status while serving 
in Iraq, injuries which are indicative of mild traumatic brain injury (Hoge et al. 2008). 
However some symptoms associated with postconcussive syndrome, such as headaches, 
difficulty with concentration, and memory loss, overlap with post traumatic stress 
disorder further complicating diagnosis of mild TBI in troops (Bryant 2001) (Table 1.1). 
Many of these troops presenting with postconcussive symptoms experienced no overt 
head trauma but share a common link, blast exposure. 
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Table 1.1. Symptoms of posttraumatic stress disorder and traumatic brain injury. 
N/A=not applicable (modified from Bryant 2001) 
 
Symptom PTSD TBI  
Depersonalization Present Present  
Amnesia Present Present  
Social Detachment Present Present  
Nightmares  Present N/A  
Insomnia Present Present  
Irritability Present Present  
Concentration Deficits Present Present  
Hypervigilence Present N/A  
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1.1.3 TBI pathology and the secondary injury cascade 
 TBIs result from a mechanical input that directly damages tissue (primary 
response) which initiates a complex secondary injury cascade (secondary response) 
(LaPlaca et al. 2007). The primary response involves blood vessel damage, axonal 
shearing, and cellular damage (Gaetz 2004; Smith et al. 2003). Vascular changes are a 
key event and may result in decreased cerebral blood flow leading to ischemic tissue and 
subsequent neuronal death (Nolan 2005). Brain edema is hypothesized to be the primary 
contributor to the high mortality and morbidity associated with TBI (Donkin and Vink 
2010).  Edema can be classified as cytotoxic or vasogenic depending on the source of the 
water. Cytotoxic edema represents an increase in intracellular water content with a 
corresponding decrease in extracellular water. Vasogenic edema is the result of 
movement of water from the vasculature into the extracellular space which may occur as 
a result of blood brain barrier (BBB) breakdown following trauma. Vasogenic, but not 
Cytotoxic, edema results in an increase in intracranial pressure.  
 Following TBI, there is progressive neurodegeneration that peaks between 48-72 
h post-injury (Hall et al. 2005).  Associated with this secondary injury is a several fold 
increase in extracellular glutamate (Faden et al. 1989; Matsushita et al. 2000; Yi and 
Hazell 2006) (Fig. 1.2). Increased glutamate results in the activation of α-amino-3-
hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) receptors, which cause 
depolarization (Rho et al. 2010). This increase in glutamate can also lead to the activation 
of voltage dependent Na+ channels, leading to further depolarization resulting from 
increased Na+ entry into the cell and osmotic swelling of the neuron as Cl– passively 
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enters the cell, causing an influx of water. Aberrant depolarization can also result in the 
removal of the Mg2+ block from N-methyl-daspartate (NMDA) receptors, allowing them 
to be activated by glutamate. Activation of NMDA receptors and group I metabotropic 
glutamate receptors allows Ca2+ influx into the neuron, subsequently activating 
downstream mediators of programmed cell death (Sullivan et al. 2005; Walker 2007). 
This disruption of Ca2+ homeostasis is believed to underlie glutamate-mediated toxicity 
(excitotoxicity). The increase in intracellular calcium may cause sustained depolarization, 
ionic imbalance, increased intracranial pressure (ICP), cerebral edema, calpain activation, 
decreased ATP production, and increased reactive oxygen species (ROS) (Sullivan, 2005; 
Yi and Hazell, 2006). In order to maintain neuronal Ca2+ homeostasis during periods of 
excitotoxicity mitochondria serve as high-capacity Ca2+sinks. The role mitochondria play 
in TBI neuropathology will be discussed in detail in a later section. 
 In addition to excitotoxicity, oxidative damage and inflammation are important 
components of the secondary injury cascade. The brain is especially vulnerable to 
oxidative damage as it accounts for approximately 20 % of basal O2 consumption, is rich 
in peroxidizable  membranous polyunsaturated fatty acids, and contains large amounts of 
iron (Halliwell and Gutteridge 2007; Patel 2002; Rho 2004). Oxidative damage has been 
shown to occur early (30 min-6 h) and spatially overlaps but temporally precedes peak 
neurodegeneration (48 h); indicating a role for oxidative damage in secondary injury 
(Deng et al. 2007). Post-TBI there are numerous sources of superoxide which include: 
microglia, macrophages, arachidonic acid cascade (i.e. 5-lipoxygenase activity), 
mitochondria, and dopamine oxidation (Lim and Lajtha 2006). Through a series of 
reactions superoxide can form either the hydroxyl radical, nitrogen dioxide, or carbonate 
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radical which can initiate lipid peroxidation or protein carbonylation. Additionally, the 
formation of 3-nitrotyrosine, by nitrogen dioxide, can alter protein structure and function 
and therefore contributes to post-trauma pathology (Reed et al. 2009). Taken together, it 
is evident that protein nitration and lipid peroxidation are early hallmarks of CNS injury 
(Hall and Braughler 1993).  Other evidence that implicates oxidative damage in TBI 
neuropathology is the observation that antioxidant therapy is neuroprotective and 
improves behavioral outcome (Hall et al. 2010; Mustafa et al. 2010; Singleton et al. 
2010). 
 Immune activation is common among neurodegenerative diseases such as 
Alzheimer’s disease, Parkinson’s disease, stroke, multiple sclerosis, and TBI (Amor et al. 
2010). The notion that the CNS is “immune privileged” has been challenged recently and 
evidence exists that demonstrates that the CNS is not isolated from the immune system 
following TBI (Morganti-Kossmann et al. 2007). Circulating leukocytes have been 
shown to transmigrate into the CNS following vascular disruption and activate resident 
immune cells (microglia and astrocytes) (Hickey et al. 1991). Activation of microglia 
occurs rapidly (6-48 h) following diffuse TBI and is followed by persistent activation (7-
28 days) with phagocytic activity (Kelley et al. 2007). Activated microglia secrete pro-
inflammatory cytokines and cytotoxic factors which exacerbate the immune response and 
promote cell death (Morganti-Kossmann et al. 2002). Tumor necrosis factor (TNF) is 
rapidly released after injury and acts initially as a pro-inflammatory cytokine (Morganti-
Kossmann et al. 2002). Interestingly the production of TNF stimulates production of 
interleukin-6, an anti-inflammatory cytokine, which in-turn inhibits TNF synthesis. 
Immunosuppresion using various immunosuppressants including cyclosporin A, FK506, 
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rapamycin, and methylprednisolone following neurotrauma has been shown to be 
neuroprotective (Hailer 2008). Therefore, inflammation represents one component of the 
secondary injury cascade that may be amenable to therapeutic intervention.   
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Figure 1.2. The excitotoxic cascade following injury. Injury results in increased levels of 
extracellular glutamate causing influxes of Ca2+ into the dendrite via NMDA receptor 
activation. If unchecked, this Ca2+ influx into neurons can result in a subsequent loss of 
neuronal Ca2+ homeostasis. This disruption of Ca2+ homeostasis is believed to be a 
defining factor of glutamate-mediated toxicity. Excessive mitochondrial Ca2+ results in 
mitochondrial dysfunction. 
11 
 
1.2 Mitochondria and TBI 
 
 Approximately 800 million years ago a symbiotic relationship between two cells 
led to the uptake of one cell by the other and made the development of multicellular 
organisms possible (Scheffler 2008). Chondros (Greek), Korn (German) or grain 
(English) were early (mid-1800s) descriptions of the morphology of distinct intracellular 
structures that later (1898) became known as mitochondria. In the early 1900s Kingsbury, 
Lehninger, and Warburg hypothesized that mitochondria were associated with cellular 
respiration. Later, Mitochondria would become known as the reliable “powerhouse of the 
cell” (Nicholls and Ferguson 2002). Now it appears that mitochondria not only produce 
cellular energy but are also involved in the life and death of the cell. Recently 
mitochondrial dysfunction has been implicated in a host of neurodegenerative disorders, 
such as stroke, spinal cord injury, TBI, and Alzheimer’s disease (Sullivan et al. 2005).      
1.2.1 Mitochondrial function 
 Mitochondria have an inner and outer membrane, each with its own specific 
functions. The outer mitochondrial membrane contains porins which are non-specific 
pores for molecules less than 10 kDa. The inner membrane is energy transducing and 
contains components of the electron transport chain (ETC) along with specific carrier 
proteins. Additionally the inner membrane exhibits folds, known as cristae, which act as 
independent compartments (Zick et al. 2009). The space between the membranes is 
referred to as the inter-membrane space and the internal compartment is known as the 
matrix. The matrix contains enzymes related to the citric acid cycle. The citric acid cycle 
reduces NAD+ to NADH. Electrons are then passed from NADH to the ETC. 
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 Mitochondria sustain the activity of neurons by producing ATP via the ETC (Fig. 
1.3). The ETC is a series of redox reactions involving the transfer of electrons from one 
carrier to the next (Alberts 2002). Electrons are transferred from carriers with low redox 
potentials to carriers with high redox potentials. ETC chain carriers include cytochromes, 
iron-sulfur proteins, and coenzyme Q. Complex I (NADH dehydrogenase) catalyzes the 
transfer of two electrons from NADH to coenzyme Q (Nicholls 2002). Complex III 
(ubiquinol-cytochrome c oxioreductase) catalyzes the transfer of electrons from 
coenzyme Q to cytochrome c. Complex IV (cytochrome c oxidase) reduces one molecule 
of oxygen to two molecules of water. As electrons are transported through Complexes I, 
III, and IV protons are pumped into the inner membrane space, generating an 
electrochemical gradient. This store of energy is used to generate ATP via the ATP 
synthase.  
  Superoxide production is a byproduct of electron transport and occurs when 
electrons escape or slip from the complexes and reduce O2 due to a backup of electrons in 
the ETS. ROS production is linked to Δψ such that a high Δψ promotes increased ROS 
production (Sullivan and Brown 2005). High Δψ results in altered redox potential of ETC 
carriers and an increase in the half-life time of ubisemiquinone leading to increased ROS 
production. Also, any damage to components of the ETC could lead to a stalling of 
reduced intermediates of the ETC which would increase the probability of an electron 
slipping and reducing O2 to form ROS. 
 In addition to producing the majority of ATP for the cell mitochondria also 
regulate intracellular calcium levels. Mitchondrial Ca2+ accumulation is dependent upon a  
13 
 
 
Figure 1.3. The mitochondrial electron transport chain (ETS). As electrons are 
transported down the ETS, complexes I, III, and IV translocate protons from the matrix, 
generating an electrochemical gradient. This store of energy can then be coupled to ATP 
production as protons move down the gradient and back into the matrix via F0F1 ATP 
synthase. Superoxide production is a byproduct of electron transport. 
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Ca2+ uniporter, Na+/Ca2+ antiporter, and H+/Na+ antiporter (Gunter and Gunter 1994; 
Scheffler 2008). The Ca2+ uniporter transports Ca2+ into the matrix in response to Δψ. 
Ca2+ efflux is driven by Na+/Ca2+ exchange which is driven by H+/Na+ exchange. Matrix 
Ca2+ is buffered by forming a complex with phosphate (calcium-phosphate gel) (Nicholls 
and Ferguson 2002). Physiologically, mitochondrial Ca2+ acts as an activator of several 
key enzymes involved in oxidative phosporylation (i.e. pyruvate dehyrdrogenase) 
(Gunter and Gunter 2001; Scheffler 2008). In response to rises in intracellular Ca2+ levels 
mitochondria can act as a temporary sink for Ca2+ and maintain cytoplasmic Ca2+ 
homeostasis. However, excessive mitochondrial Ca2+ loading (i.e. during periods of 
excitotoxicity) results in cell death initiation and will be discussed in detail in subsequent 
sections. 
1.2.2 Mitochondrial permeability transition  
 Excessive mitochondrial Ca2+ cycling/loading can result in mitochondrial 
permeability transition (mPT) (Crompton and Costi 1990; Haworth and Hunter 1979). 
mPT is the sudden increase in the inner membrane permeability to solutes of molecular 
mass less than 1500 Da and was originally described by Hunter and Haworth in the 1970s 
(Haworth and Hunter 1979; Hunter and Haworth 1979a; Hunter and Haworth 1979b; 
Zoratti and Szabo 1995). mPT results in a loss of Δψ which uncouples electron transport 
from the production of ATP (Halestrap 2009). Also mPT results in further mitochondrial 
swelling, rupture of the outer mitochondrial membrane, and increased ROS production 
(Mazzeo et al. 2009; Sullivan et al. 2005). mPT is thought to be mediated by opening of a 
mega channel known as the mitochondrial permeability transition pore (mPTP) (Sullivan 
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et al. 2005). Although the exact composition of the mPTP remains to be elucidated, the 
three most characterized components include the adenine nucleotide translocase (ANT), 
cyclophilin D (CypD), and the volatage dependent anion channel (VDAC) (Fig. 1.4).  
 CypD is an 18 kDa matrix peptidyl-prolyl cis-trans isomerase (PPIase) encoded 
by the nuclear gene PPIF that binds to the matrix face of ANT (Halestrap 2009; 
Halestrap and Brenner 2003). PPIase activity is associated with an ability to catalyze the 
isomerization of protein proline residues, which has dramatic effects on protein structure 
and function. This Binding of CypD, in the presence of high levels of Ca2+, results in a 
conformational change in ANT that converts ANT into a non-specific pore located in the 
inner membrane (Griffiths and Halestrap 1991; Halestrap and Brenner 2003). The 
interaction of the CypD/ANT complex with VDAC results in the formation of the mPTP.  
In addition to Ca2+ induced mPTP, oxidative stress has been shown to promote mPTP by 
enhancing the binding of CypD to ANT (Halestrap et al. 1997). This interaction between 
ANT and CypD is blocked by cyclosporin A (CsA) (Crompton et al. 1988). Recent 
studies in CypD knockout mice have demonstrated that mitochondria lacking CypD are 
resistant to Ca2+ and ROS induced mPTP; further validating CypD involvement in mPTP. 
Additionally, CypD knockout does protect against cardiac ischemia-reperfusion injury 
(Nakagawa et al. 2005). However, CypD knockout did not protect against cell death 
induced by pro-apoptotic Bcl-2 family members (Baines et al. 2005). This indicates that 
cell death mediated by mPT may occur through two mechanisms; either CypD-dependent 
mechanism or CypD-independent mechanism (Fig. 1.5).  
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Figure 1.4. Mitochondrial permeability transition pore. The mPTP is a conductance pore 
that spans the inner and outer mitochondrial membranes and is putatively composed of 
the adenine nucleotide translocase (ANT) of the inner membrane, matrix cyclophilin D 
(CypD), and the voltage-dependent anion channel (VDAC) of the outer membrane. 
(Right) Under normal conditions bound adenine nucleotides inhibit the opening of the 
mPTP. (Left) Under pathophysiological conditions oxidative stress results in a 
conformational change in ANT that prevents the binding of adenine nucleotides. In the 
presence of high Ca2+ CypD binds to ANT and promotes formation of the mPTP. 
Opening of the mPTP results in the release of apoptotic proteins (i.e. cytochrome C 
(CytC) and apoptosis inducing factor (AIF). 
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Figure 1.5. The role of CypD in cell death. Ca2+ and ROS have been shown to promote 
mPT and cell death through a CypD-dependent mechanism. Pro-apoptotic Bcl-2 family 
members (i.e. Bax and Bak) induce mPT and cell death in a CypD-independent 
mechanism. Likely, both pathways coexist. 
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Following mPTP, pro-apoptotic proteins such as Smac/DIABLO, apoptosis inducing 
factor (AIF), and cytochrome c can be released from the mitochondria, leading to 
apoptosis (Fig. 1.6). Once released, cytochrome c forms a ATP-dependent complex with 
apoptosis-inducing factor (Apaf-1) that in turn will activate caspase-9 and caspase-3 and 
results in caspase-dependent cell death (Stoica and Faden 2010). In contrast, following 
release AIF translocates to the nucleus where it causes DNA fragmentation in a caspase-
independent mechanism. The latter cell death pathway does not require ATP and can 
proceed under conditions of bioenergetic compromise, such as in TBI. 
1.2.3 Mitochondrial dysfunction following TBI 
 It is well established that mitochondrial dysfunction occurs early after TBI 
(Robertson et al. 2007; Singh et al. 2006; Xiong et al. 1997). Associated with this early 
mitochondrial dysfunction is an increase in ROS production, protein nitration, and lipid 
peroxidation (Azbill et al. 1997; Braughler and Hall 1992; Hall et al. 1992). Specifically 
oxidative damage to cortical and hippocamapal mitochondria has been shown to occur as 
early as 30 min following TBI (Singh et al. 2006). Administration of antioxidants 
following TBI has been demonstrated to improve mitochondrial function (Mustafa et al. 
2010; Xiong et al. 1999; Xiong et al. 2005).  As a consequence of increased 
mitochondrial Ca2+ and oxidative damage mitochondrial bioenergetics are compromised 
following TBI (Sullivan et al. 2005). Additionally, mitochondrial calcium sensitivity has 
been shown to decrease following TBI (Lifshitz et al. 2003). Also cytochrome c release is 
well documented in TBI (Robertson et al. 2007; Sullivan et al. 2002).  
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Figure 1.6. Highly simplified schematic diagram illustrating the pivotal role of 
mitochondria in apoptotic and necrotic neuronal cell death following excitotoxic insult. 
The excitatory amino acid glutamate increases Ca2+ influx into neurons. Mitochondria 
sequester the Ca2+ in an effort to maintain cytosolic Ca2+ homeostasis. Excessive 
mitochondrial Ca2+ cycling/loading can result in mitochondrial permeability that can be 
mediated by the mitochondrial permeability transition pore (mPTP) opening or via 
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increased permeability of the outer membrane without mPTP opening. In either case, pro-
apoptotic proteins such as Smac/DIABLO, apoptosisinducing factor (AIF), and 
cytochrome c (Cyto C) can be released from the mitochondria, leading to activation of 
downstream caspases and apoptosis. Ca2+-induced mPT results in increased conductance 
of the inner membrane, mitochondrial swelling, loss of ATP production due to decreased 
membrane potential (Δψ), and increased reactive oxygen species (ROS) production. 
These events promote mPT and can lead to necrosis depending on the extent and severity 
of the insult or injury. 
 
 There is a wealth of evidence that demonstrates that mPTP inhibition following 
TBI is neuroprotective. Administration of CsA following TBI has proven to be 
efficacious in multiple models of TBI (Albensi et al. 2000; Alessandri et al. 2002; Buki et 
al. 1999; Kilbaugh et al. 2011; Okonkwo et al. 1999; Okonkwo and Povlishock 1999; 
Scheff and Sullivan 1999; Sullivan et al. 2000b; Sullivan et al. 2000c; Sullivan et al. 
1999) as well as in other CNS injury models (Friberg et al. 1998; Yoshimoto and Siesjo 
1999). Recently the non-immunosuppressive CsA analog, NIM811, was shown to 
improve motor function, improve mitochondrial function, decrease oxidative damage, 
and decrease neurodegeneration following TBI (Mbye et al. 2009; Mbye et al. 2008).  
 
1.3 Blast physics and injury pathology 
 The Friedlander wave form mathematically describes the blast overpressure 
(BOP) event generated by an explosion which includes a shock wave that is generated by 
an instantaneous rise in atmospheric pressure (high-pressure shock wave) that decays 
exponentially from the origin of the blast (Elsayed 1997) (Fig. 1.7). Following the initial 
shock wave the pressure may drop below ambient pressure before returning to baseline.  
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Figure 1.7. Friedlander wave. Open-field waveform characterized by an instantaneous 
rise in ambient pressure (positive phase), followed by exponential decay that may drop 
below ambient pressure (negative phase).  
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It is important to note that this wave form only applies to blasts that occur in open air 
environments while blasts that occur in enclosed environments display more complex 
wave forms (Mayorga 1997). The duration of overpressure, the time between the initial 
increases in pressure until its return to baseline, has been shown to have a direct impact 
on injury severity (Elsayed 1997). Primary blast injuries are caused by the direct effects 
of either overpressurization or underpressurization (barotrauma) (DePalma et al. 2005). 
Air-filled organs and air-fluid interfaces are the most common sites of primary blast 
injury, this is due to dynamic pressure differences at tissue density (air-fluid) interfaces 
caused by the interaction of a high frequency stress wave and lower frequency shear 
wave (Finkel 2006). Pulmonary barotrauma is one of the most common and life 
threatening primary blast injuries and often results in pulmonary edema (Finkel 2006). As 
a consequence of lung injury hypotension and hypoxemic secondary events are likely 
contributors to overall outcome following blast (Dewitt and Prough 2008). Secondary 
blast injuries are caused by objects set in motion by the shock wave that come in contact 
with people. Tertiary blast injuries result from individuals being propelled away from the 
site of the blast; these injuries are caused by individuals coming in contact with objects. 
Quaternary blast injuries are considered injuries not associated with primary, secondary, 
or tertiary injuries; such as burns, radiation exposure, and toxic inhalation (DePalma et al. 
2005). Secondary and tertiary injuries are not specific to air filled organs and are capable 
of producing brain injury, however little is known about the possibility of primary brain 
blast injuries. 
 BOP is commonly modeled using blast tubes or shock tubes and less often in an 
open-field environment (Cernak and Noble-Haeusslein 2010). In both tubes the animal is 
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positioned in a holder that prevents secondary and tertiary blast injuries.  Blast tube 
shockwaves are generated by an explosion (i.e. combustion of a flammable gas or 
detonation of an explosive charge). Whereas shockwaves generated in a shock tube are 
produced by compressed air or gas. A shock tube is composed of a compression chamber 
separated from an expansion chamber by a rupturable membrane (i.e. mylar membrane).  
The compression chamber is loaded with air or gas until the failure point of the 
membrane is reached, at which time the membrane ruptures and releases the gas/air into 
the expansion chamber. The thickness of the membrane determines the peak overpressure 
such that the thicker the membrane the higher the peak overpressure (Elsayed 1997). The 
rapidly expanding gas/air results in a shockwave. 
 High levels of BOP, even without skull fracture, are capable of producing cerebral 
contusion and subdural hemorrhage (Mayorga 1997). Recently pressure waves with 
intensities capable of damaging nervous tissue were detected in the brains of rats exposed 
to low level (40 kPa) BOP (Chavko et al. 2006). Although animal studies evaluating the 
effect of BOP on the CNS are limited, some have shown the susceptibility of the CNS to 
primary blast forces. One group studied the effect of BOP on the CNS with rats exposed 
to a severe level of BOP; they reported cognitive deficits, neuronal swellings, glial 
reaction, and oxidative stress (Cernak et al. 2001a; Cernak et al. 2001b). Another group 
showed that electroencephalogram activity was depressed in pigs exposed to a mild BOP 
event (Axelsson et al. 2000). More recent experimental reports in rats and pigs have 
further characterized the neuropathology that ensues following BOP exposure. In order to 
delineate the systemic effects versus the direct effects of BOP on brain injury, Long and 
colleagues recently equipped rats with Kevlar vests in order to protect the abdomen and 
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thorax from BOP. This study found that rats equipped with vests had less fiber 
degeneration than those without vests. Also this study reported that rats exposed to 126 
kPa BOP showed less neuropathology than those exposed to 147 kPa, indicating a dose 
response between level of blast and neuropathology (Long et al., 2009). A recent swine 
model of BOP indicated that pigs exposed to BOP exhibited cortical fiber degeneration 
and astrocytic activation (Bauman et al., 2009). Behavioral changes and 
neuropathological signs of brain injury as a result of exposure to low levels of BOP have 
also been reported (Saljo et al. 2008; Saljo et al. 2009c). 
 
1.4 Specific Aims and Hypotheses  
 Inhibition of CypD with CsA and NIM811 following TBI has been shown to be 
neuroprotective. However, both NIM811 and CsA have inverted U dose responses 
following TBI. It remains to be determined whether the observed dose responses are due 
to the interaction with CypD and/or other off-target interactions. Therefore CypD null 
mice will be used to determine the contribution of CypD to secondary injury and to 
provide further validation of CypD’s potential as a therapeutic target following TBI (Fig. 
1.8). We hypothesize that genetic knockout of CypD will attenuate formation of the 
mPTP, which will translate into increased cortical tissue sparing, increase hippocampal 
neuron survival, and improved mitochondrial bioenergetics. 
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Fig. 1.8. Model of the hypothesis that CypD is an essential mediator of cell death 
following TBI. CypD knockout studies have demonstrated that, depending on the cell 
death signal, mPT mediated cell death may proceed through either a CypD-dependent 
mechanism or a CypD-independent mechanism. TBI is proposed to engage both 
mechanisms. Therefore, pharmacological inhibition and genetic knockout of CypD is 
hypothesized to provide neuroprotection following TBI. 
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 Because there may be a prerequisite for CypD for normal physiological 
functioning, genetic ablation of CypD could prove detrimental. As such partial 
pharmacological inhibition of CypD, rather than total inhibition, could prove to be a 
better therapeutic strategy. The utility of CsA is limited due to its interaction with 
calcineurin and resultant toxicity. Since NIM811 is less toxic than CsA and can be 
administered in vivo at higher levels it may have greater therapeutic potential. NIM811 
has been shown to attenuate mitochondrial dysfunction, decrease neurodegeneration, and 
improve motor function following TBI, thus we hypothesize that administration of 
NIM811 will improve cognition, increase tissue sparing, and improve mitochondrial 
function. 
 Clinical and experimental data have shown that blast exposure does result in 
neuropathology. In order to begin to understand the mechanism (s) of injury following 
blast traumatic brain injury (bTBI) and to develop treatment strategies for bTBI it is 
important to develop clinically relevant bTBI models. Therefore, we aim to characterize 
the time-course of “classical” TBI markers of pathology following bTBI with the 
eventual goal of selecting therapeutic targets for bTBI. 
In order to test these hypotheses we have formulated the following specific aims: 
Specific aim 1 will evaluate the hypothesis that genetic ablation of CypD will improve 
behavioral function and provide neuroprotection following TBI. The effects of CypD 
knockout on neuroprotection following TBI will be assessed using cortical tissue sparing 
analysis and stereological assessment of hippocampal cell counts. Additonally, the effects 
of CypD knockout on mitochondrial function following TBI will be determined. 
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Specific aim 2 will examine the hypothesis that pharmacological inhibition of CypD with 
NIM811 will reduce tissue damage, attenuate mitochondrial dysfunction, and improve 
functional outcome following TBI. MWM will be used to determine the effect of NIM811 
on cognitive function following TBI. Following TBI, isolated mitochondria from 
NIM811 and vehicle administered rats will be assayed to determine the effects of 
treatment on mitochondrial function. Neuroprotective effects of NIM811 will be 
determined using cortical tissue sparing analysis. 
Specific aim 3 will test the hypothesis that BOP exposure will result in oxidative damage, 
inflammation, and blood brain barrier (BBB) breakdown. Immunohistochemistry using 
antibodies against 3-nitrotyrosine, 4-hydroxynonenal, IgG, and Cd11b/c will be used to 
determine the profile of oxidative damage, inflammation, and blood brain barrier (BBB) 
breakdown following TBI. Additionally, [3H]-PK11195 autoradiography will be used to 
determine the extent of microglial activation following TBI. 
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2. CHAPTER 2 
Genetic Approach to Elucidate the Role of Cyclophilin D in TBI Pathology 
2.1 Introduction 
 Cell death following TBI occurs in two waves; an immediate wave of cell death 
as a consequence of physical injury and a secondary wave of cell death resulting from 
biochemical and/or physiological signals (Stoica and Faden 2010). Excitotoxicity 
following injury results in disrupted intracellular Ca2+ homeostasis. In an effort to 
maintain cytosolic Ca2+ levels mitochondria buffer rises in intracellular Ca2+. However, 
mitochondrial Ca2+ buffering is finite and excessive mitochondrial Ca2+ loading results in 
mitochondrial dysfunction. As such mitochondrial dysfunction has been implicated as a 
key pathological event following TBI. Mitochondria regulate both necrotic and apoptotic 
cell death pathways likely via modulation of the mPTP (Green and Reed 1998; Schneider 
2005) . Although the exact molecular identity of the mPTP is unknown the adenine 
nucleotide translocase (ANT) of the inner membrane, the voltage-dependent anion 
channel (VDAC) of the outer membrane, and the matrix-specific peptidyl-prolyl cis–
trans isomerase cyclophilin D (CypD) appear to be mPTP components. Cyp-D 
translocates from the matrix to the mPTP where it interacts with ANT and promotes pore 
formation (Lemasters, et al., 2009).  
 Recently, Ca2+ and ROS were shown to promote pore formation by a CypD 
dependent mechanism (Baines et al. 2005; Basso et al. 2005). Also, CypD knockout 
resulted in remarkable protection from cardiac ischemia-reperfusion injury (Nakagawa et 
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al. 2005).  However, not all cell death pathways initiated by the mitochondria are CypD 
dependent (i.e. Bcl-2 family members induce apoptosis by a CypD independent 
mechanism) (Green and Kroemer 2004). CypD knockout did not protect against cell 
death mediated by Bcl-2 family members (Baines et al. 2005).  
 The connection between CypD and cell death following TBI has been supported 
by studies demonstrating that inhibition of mPTP formation with NIM811 and CsA is 
neuroprotective. Presumably, the neuroprotective actions of CsA and NIM811 are 
attributable to their inhibition of CypD, which prevents the binding of CypD to ANT and 
formation of the mPTP (Nicolli, et al., 1996). However, it is difficult to discern the 
protective mechanisms of NIM811 and CsA given that both have targets other than 
CypD. Since cell death may occur independent of CypD the overall role CypD plays in 
cell death following TBI remains largely unknown. 
 To further elucidate the role CypD plays in neuropathology following TBI mice 
lacking the CypD enconding gene Ppif were subjected to a controlled cortical impact 
model of TBI. We hypothesized that genetic knockout of CypD would confer 
neuroprotection following TBI. At 18 days post-injury cortical tissue sparing assessment 
was performed. To determine the effects of   CypD knockout on hippocampal cell 
survival, neurons were counted for regions dentate gyrus (DG), CA3, and CA1 using the 
optical dissector method. Next we determined the effects of CypD knockout on 
mitochondrial function following TBI.  The data demonstrate that knockout of CypD, 
likely via maintenance of mitochondrial homeostasis, spares cortical tissue and protects 
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CA3 neurons following TBI and support the hypothesis that CypD is an important 
mediator of cell death following TBI.  
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2.2 Methods 
2.2.1 Animals, injury, and experimental design 
 All experimental animal procedures were approved by the Animal Care and Use 
Committee at the University of Kentucky. Adult wild-type (C57BL/6) and CypD 
knockout mice were subjected to a severe (1.0 mm) unilateral controlled cortical 
contusion TBI or sham-operation (n=18). Briefly, the skull was exposed through a 
midline incision and an approximately 4 mm craniotomy was made lateral to the midline 
and centered between bregma and lambda. A cortical contusion was produced using a 
pneumatically driven injury device with a 3 mm tip as previously described (Mbye et al. 
2008). Following injury a prosthetic skull cap was glued over the craniotomy site. 
Animals remained on a 37⁰ heating pad until their righting reflex had returned.  
 
2.2.2 Tissue processing and measurements of tissue sparing  
 At 18 days post-injury, wild-type and CypD knockout mice were anesthetized by 
an overdose of pentobarbital and transcardially perfused with physiological saline 
followed by 4% paraformaldehyde (n=4-5/group). After removal, the brains were placed 
in 4% paraformaldehyde-sucrose (15%) for an additional 24 h. Coronal sections (30 μm) 
were then cut using a freezing microtome, throughout the rostrocaudal extent of the brain, 
extending through the septal area to the most posterior extent of the hippocampus.  
 
2.2.3 Optical Fractionator Method 
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 All sampling was conducted using an Olympus BX51 microscope with a 60 X oil 
objective, with an ASI automated stage (Eugene, OR). Bioquant Image analysis software 
(R and M Biometrics, Memphis, TN) was used to estimate the total cell number in 
ipsilateral hippocampal regions CA1, CA3, and DG using the optical fractionator method 
as previously described (Baldwin et al. 1997). Briefly, this method involves sampling a 
known fraction of the section thickness, under a known fraction of the sectional area, in a 
known fraction of the sections that contain the structure. The total number of neurons (N) 
is estimated by: N = ƩQ * t/h * 1/asf * 1/ssf, where ƩQ is the number of neurons counted 
in the optical dissectors, t is the tissue thickness (30 µm), h is the height of the dissector 
(25 µm), 1/asf is the counting grid area (100 X 100)/the dissector area (CA3, CA1-15 µm 
X 15 µm; DG-10 µm X 10 µm), and 1/ssf is the sampling section fraction (12).  
 
2.2.4Mitochondrial isolation and respiration analysis 
 At 6 h post-injury wild-type and CypD knockout mice were asphyxiated with CO2 
until unconscious, decapitated, and the brains were rapidly removed and placed in 
isolation buffer (215 mM mannitol, 75 mM sucrose, 0.1% BSA, 20 mM HEPES, and 1 
mM EGTA; pH 7.2) (n=3/group). The cortices were dissected with a 3 mm-diameter 
punch centered on the site of impact. The cortical tissue punch contained tissue from the 
site of the impact and the surrounding penumbra. The tissue punches were homogenized 
and isolated by differential centrifugation as previously described (Singh, et al., 2006). 
Briefly, the homogenate was centrifuged twice at 1300 xg for 3 min. The pellet was 
discarded, and the supernatant was further centrifuged at 13,000 xg for 10 min. In order 
to release synaptic mitochondria, the crude mitochondrial pellet was subsequently 
33 
 
subjected to nitrogen decompression using a nitrogen cell disruption bomb (1200 psi, 10 
min). After nitrogen disruption, the mitochondria were suspended in 3.5 mL of 15% 
percoll and placed on a percoll gradient consisting of 3.5 mL of 24% percoll and 3.5 mL 
of 40% percoll in 13-mL ultraclear tubes. The gradient was centrifuged in a fixed-angle 
rotor at 30,400 xg for 10 min at 4°C. The fraction accumulated at the interphase of the 
40% and 24% percoll layers was carefully removed and diluted with isolation buffer 
without EGTA, then centrifuged at 12,300 xg for 10 min at 4°C. The supernatants were 
carefully removed, and the pellet was resuspended in isolation buffer without EGTA and 
centrifuged at 13,000 xg for 10 min at 4°C. The mitochondrial pellets were recentrifuged 
at 10,000 xg for 5 min at 4°C to yield tighter pellets. The final mitochondrial pellet was 
resuspended in isolation buffer without EGTA to yield a concentration of ~10 mg/mL. 
The protein concentration was determined using a bicinchoninic acid protein assay kit 
(Pierce, Rockford, IL). 
 Mitochondrial respiration was measured using a Seahorse Biosciences XF24 Flux 
Analyzer (North Billerica, MA) as previously described (Sauerbeck et al. 2011). Briefly, 
pyruvate plus malate plus ADP, oligomycin, FCCP, and rotenone plus succinate were 
injected sequentially through ports A–D, respectively, in the Seahorse Flux Pak 
cartridges to yield final concentrations of 5 mM (pyruvate), 2.5 mM (malate), 1 mM 
(ADP), 1 μg/ml (oligomycin), 1 μM (FCCP) and 100 nM (rotenone), 10 mM (succinate), 
respectively.  
 
2.2.5 Statistics 
34 
 
For all statistical comparisons, significance was set at p < 0.05. Tissue sparing 
assessment data were analyzed using unpaired t-test. Cell count data were analyzed using 
a two-factor ANOVA followed by Bonferroni post-hoc analysis. Mitochondrial data were 
analyzed using one-way ANOVA followed by SNK post-hoc analysis.  
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2.3 Results  
2.3.1 Cyclophilin D knockout increases tissue sparing following TBI 
In order to determine the effects of CypD knockout on tissue sparing following TBI, 
wild-type and CypD knockout mice were subjected to a severe (1.0 mm) CCI TBI. In 
these experiments cortical tissue sparing was determined at 18 days post-injury utilizing 
the Calvalieri method. CypD knockout mice demonstrated a significant increase in tissue 
sparing (84.1 ± 2.1) compared to wild-type mice (76.2 ± 2.248) (p < 0.03) (Fig. 2.1).  
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Figure 2.1. CypD knockout increases tissue sparing following TBI. Quantitative 
assessment of tissue sparing revealed that CypD knockout animals demonstrated a 
significant increase in tissue sparing when compared to wild-type animals. Data points 
represent group means ± SD. *p = 0.033. 
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2.3.2 Cyclophilin D knockout protects CA3 hippocampal neurons 
The number of surviving CA1, CA3 and DG neurons were estimated using the optical 
fractionator method at 18 days post-injury (Fig. 2.2). In wild-type mice, injury 
significantly decreased the number of neurons in ipsilateral CA1 [F(1,16) = 110.7; p < 
0.001], CA3 [F(1,16) = 21.6; p < 0.001],  and DG [F(1,16) = 120.1; p < 0.01]. In CypD 
knockout mice, injury significantly decreased the number of neurons in ipsilateral CA1 
[F(1,16) = 120.1; p < 0.001] and DG [F(1,16) = 120.1; p < 0.001]. In ipsilateral CA3 of 
CypD knockout TBI mice, numbers of surviving neurons were not significantly different 
than CypD knockout sham mice.  
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Figure 2.2. CypD knockout protects CA3 hippocampal neurons following TBI. Injury 
significantly decreased the number of neurons in CA1 (A), DG (B), and CA3 (C) in wild-
type mice. CypD knockout protected CA3 neurons from injury-induced cell loss. Data 
points represent group means ± SD. *p< 0.05. 
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2.3.3 Cyclophilin D knockout improves mitochondrial complex I driven respiration 
 
In order to determine the effects of CypD knockout on mitochondrial respiration 
following TBI, mitochondria were isolated at 6 h post-injury from the ipsilateral cortex of 
wild-type and CypD knockout mice. In the presence of pyruvate plus malate plus ADP, 
injury-induced impairments in complex I driven respiration (State III respiration) were 
attenuated by CypD knockout (p<0.05) (Fig. 2.3). Complex II driven respiration was 
significantly reduced in both CypD knockout and wild-type mice (p<0.05). 
 
 
 
 
 
 
 
 
 
 
 
40 
 
0
100
200
300
400
500
600
700
800
900
1000
1100
State III State IV
WT-Sham
WT-injured
KO-injured
*
#
##
State V-CII
O
C
R
 (p
M
ol
es
 O
2/
m
in
)
 
 
Figure 2.3. CypD knockout attenuates mitochondrial dysfunction following TBI. At 6 h 
post-injury wild-type mice (white bars) complex I driven respiration was significantly 
reduced compared to sham (black bars); CypD knockout attenuated this dysfunction.  
Data points represent group means ± SD. #p< 0.05 v WT-sham, *p<0.05 v KO-injured. 
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2.4 Discussion 
 We investigated the role of Cyp-D in TBI, in which Cyp-D dependent cell death 
mechanisms have been implicated including Ca2+ dishomeostasis and increased ROS 
production. The present data for the first time demonstrates that genetic ablation of Cyp-
D is neuroprotective following TBI. Importantly, Cyp-D knockout attenuated injury-
induced inhibition of mitochondrial complex I respiration. Therefore, the present results 
confirm the key role Cyp-D plays in cell death following TBI.  
 Pharmacological studies have suggested an important role for Cyp-D in 
neurodegeneration and TBI. Administration of CsA has been shown to be neuroprotective 
following multiple experimental models of TBI (Buki et al. 1999; Kilbaugh et al. 2011; 
Okonkwo et al. 1999; Scheff and Sullivan 1999; Sullivan et al. 2000c; Sullivan et al. 
1999). Since CsA interacts with Cyp-D and inhibits calcineurin, the neuroprotective 
mechanism(s) of CsA is greatly debated. NIM811, which inhibits Cyp-D but doesn’t 
affect calcinuerin, has also been shown to have neuroprotective properties following TBI 
and spinal cord injury. However, NIM811 has a U-dose response curve following TBI 
which may indicate that NIM811 is acting through other potential off-target mechanisms. 
Genetic knockout of Cyp-D provides a novel approach for directly examining the role 
that Cyp-D plays without the confounding off-target effects of pharmacological studies.  
 The observed improvement in mitochondrial complex I activity following TBI in 
Cyp-D knockout mice likely reflects a secondary effect of inhibition of mPTP formation 
by loss of Cyp-D (Mbye et al. 2008). The attenuation of decreases in mitochondrial 
complex I respiration rates suggest that loss of Cyp-D increases mitochondrial resistance 
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to TBI. These findings are in line with studies involving mitochondria isolated from 
CypD deficient mice which showed that mitochondria lacking CypD are resistant to Ca2+ 
induced mPTP formation (Baines et al. 2005). 
 Although it is generally accepted that the mPTP plays a role in cell death the 
mechanisms underlying induction of mPTP following TBI remain unclear.  There appears 
to be two alternative routes to cell death, one that is Cyp-D dependent and an alternative 
route that is Cyp-D independent; both pathways have been implicated in TBI. An 
important question is if inhibition of one pathway is sufficient to overcome cell death or 
if inhibition of one pathway could enhance/promote the other pathway, with the same 
result either way-cell death.  There is growing evidence that suggests that Cyp-D 
knockout is protective in neurodegenerative disorder models (Du et al. 2008; Du et al. 
2011; Wang et al. 2009).  Interestingly, one study found that the prevalent cell death 
pathway after hypoxic-ischemic brain injury is developmentally regulated such that Cyp-
D dependent pathway is more critical in the development of brain injury in the adult 
(Wang et al. 2009). This study demonstrated that Cyp-D knockout significantly reduced 
hypoxic-ischemic brain injury in adult mice while knockout exacerbated the injury in 
neonatal mice. Related to this, our results indicate that maintenance of mitochondrial 
homeostasis, by the absence of Cyp-D, following TBI is protective. 
 We have previously demonstrated that continuous infusion of CsA for up to 7 
days  produces greater protection than a single dose administration of CsA following TBI 
(Sullivan et al. 2000c). Also, we have recently shown that the earlier the treatment with 
CsA is initiated following TBI the greater the neuroprotection that is afforded (Sullivan et 
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al. 2011). Taken together these results suggest that the mechanisms underlying cell death 
following TBI are active for a prolonged period of time and that early intervention 
provides the greatest benefit. Consistent with these findings, genetic knockout of Cyp-D 
indicated that following TBI complete absence of Cyp-D from the onset was indeed 
beneficial.  
 Cyp-D knockout was recently shown to protect neurons against glutamate 
triggered cell death in vitro (Li et al. 2009). Importantly, the protection was dependent on 
the severity of the glutamate insult such that protection was not observed following the 
more severe insult. This may indicate that following more severe insults that Cyp-D 
independent cell death mechanisms are more prevalent. In unpublished data from our lab 
we have shown that following a mild (0.5 mm) CCI TBI there is modest neuroprotection. 
Our results suggest that Cyp-D dependent cell death mechanisms are more prevelant in 
TBI, as Cyp-D ablation resulted in protection from mild and severe TBI. 
 This is the first study to report the effects of Cyp-D knockout in a model of 
traumatic brain injury and we showed that the lack of Cyp-D significantly decreased the 
damage associated with TBI. Thus, Cyp-D dependent cell death is critically involved in 
TBI, supporting the hypothesis that Cyp-D is a valid target for neuroprotection following 
TBI. 
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3. CHAPTER 3 
Post-injury administration of the mitochondrial permeability transition pore 
inhibitor, NIM811, is neuroprotective and improves cognition following traumatic 
brain injury in rats 
(Accepted for publication in Journal of Neurotrauma) 
3.1 Introduction  
 Traumatic brain injury (TBI) is characterized by significant neurological 
dysfunction which results from a primary rapid necrosis of tissue at the site of injury 
followed by a delayed secondary injury. Mechanisms believed to play a role in cell death 
following TBI are numerous and include excitotoxicity, inflammation, mitochondrial 
dysfunction, oxidative stress, calpain activation, and caspase activation (Deng-Bryant et 
al. 2008; Deng et al. 2007; Hall et al. 2004; Kelley et al. 2007; Lifshitz et al. 2003; 
Lifshitz et al. 2004; McGinn et al. 2009; Morganti-Kossmann et al. 2007; Saatman et al. 
2010; Singh et al. 2006). Following TBI, excessive activation of N-methyl-D-aspartate 
(NMDA) receptors by excitatory amino acids results in an elevation in cytoplasmic Ca2+ 
(Hinzman et al. 2010). Under normal conditions mitochondria primarily act to regulate 
energy metabolism and as high-capacity Ca2+ sinks (Giacomello et al. 2007). However, 
excessive mitochondrial Ca2+ loading following TBI may result in formation of the 
mitochondrial permeability transition pore (mPTP) (Sullivan et al. 2005). A consequence 
of mPTP formation is a loss of membrane potential, which supports the uncoupling of 
electron transport from ATP production. The release of pro-apoptotic molecules (i.e., 
cytochrome C, Smac/Diablo, and apoptosis inducing factor) from the mitochondria is, in 
part, orchestrated by mPTP and leads to the activation of cell death pathways (Jordan et 
al. 2003). An additional consequence of mPTP formation is the production of reactive 
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oxygen species (ROS) which contribute to cellular damage by oxidizing cellular proteins 
and lipids (Mazzeo et al. 2009). 
 Well-known components of the mPTP include the adenine nucleotide translocase 
(ANT) of the inner membrane, the voltage-dependent anion channel (VDAC or Porin) of 
the outer membrane, and the matrix-specific peptidyl-prolyl cis–trans isomerase 
cyclophilin D (Cyp-D). Cyp-D translocates from the matrix to the mPTP where it 
interacts with ANT and promotes pore formation (Lemasters et al. 2009). Cyclosporin A 
(CsA) and NIM811, inhibit the opening of mPTP by binding Cyp-D, which prevents the 
binding of Cyp-D to ANT (Nicolli et al. 1996).   
 Abundant evidence demonstrates the neuroprotective efficacy of mitochondrial 
permeability transition pore inhibition following TBI (Cook et al. 2009; Vink et al. 2001). 
Administration of CsA following TBI significantly improves mitochondrial function and 
subsequently decreases neuronal damage (Buki et al. 1999; Okonkwo and Povlishock 
1999; Scheff and Sullivan 1999; Sullivan et al. 2000b; Sullivan et al. 2000c; Sullivan et 
al. 1999). However, studies investigating the effects of CsA administration on cognition 
following TBI are limited and contradictory. In one study CsA’s neuroprotection directly 
translated into improved cognition (Alessandri et al. 2002). In contrast another study 
reported that CsA administration did not result in improved cognition following 
experimental TBI (Riess et al. 2001). Therefore the absence of cognitive data supporting 
the use of CsA following TBI warrants further investigation of mPTP inhibitors. 
  The non-immunosuppressive cyclosporin A analog, N-methyl-4-isoleucine-
cyclosporin (NIM811), lacks the ability to inhibit calcineurin and therefore can be 
administered in vivo at much higher doses than CsA (Rosenwirth et al. 1994; Waldmeier 
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et al. 2002). NIM811 has been shown to have a favorable pharmacokinetic profile with 
oral bioavailability similar to that of CsA (Rosenwirth et al. 1994). The toxicity of 
NIM811 is significantly less than CsA as indicated by inducing fewer nephrotoxic 
effects. Recently we demonstrated that a 10-mg/kg dose of NIM811 was as effective as a 
20-mg/kg dose of CsA in attenuating mitochondrial dysfunction and neurodegeneration 
and improving motor function following experimental controlled cortical impact (CCI) 
TBI in mice (Mbye et al. 2009; Mbye et al. 2008).  
  In the present study, we used the CCI TBI model to assess whether or not the 
effects of NIM811 administration to rats would duplicate the neuroprotective effects of 
NIM811 previously observed with mice and to determine if these effects would translate 
into improved cognition. Firstly, we determined the dose-response of NIM811 for 
increased tissue sparing. Secondly, we determined the effect of the optimal dose of 
NIM811 for improved cognitive performance using the Morris Water Maze (MWM). 
Thirdly, we assessed the effect of the optimal dose of NIM811 for improving 
mitochondrial function and decreasing mitochondrial oxidative damage. The results 
demonstrate that NIM811 administration is capable of both conferring neuroprotection 
and improving cognition following TBI. 
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3.2 Methods  
3.2.1 Animals, injury, and experimental design 
 All experimental animal procedures were approved by the Animal Care and Use 
Committee at the University of Kentucky. Adult male Sprague-Dawley rats weighing 
approximately 300-350 g were subjected to a severe (2.0 mm) unilateral controlled 
cortical contusion TBI or sham-operation (n=66). Surgical procedures were performed as 
previously described under 2% isoflurane (Davis et al. 2008). For tissue sparing 
assessment studies, animals were administered vehicle (100 % DMSO) or NIM811 (N-
methyl-4 isoleucinecyclosporin; Novartis Pharma Ltd., Basal, Switzerland) (5, 10, 20, or 
40 mg/kg) at 15 min and 24 h post-injury depending on group designation (n=5/group). 
Animals for behavioral studies were administered vehicle or NIM811 (10 mg/kg) at 15 
min and 24 h post-injury. Animals designated for mitochondrial studies were 
administered either vehicle or NIM811 (10 mg/kg) at 15 min post-injury (n=5/group). 
 
3.2.2 Tissue processing and measurements of lesion volume  
 At 15 days post-injury, animals were anesthetized by an overdose of pentobarbital 
and transcardially perfused with physiological saline followed by 4% paraformaldehyde. 
After removal, the brains were placed in 4% paraformaldehyde-sucrose (15%) for an 
additional 24 h. Coronal sections (50 μm) were then cut using a freezing microtome, 
throughout the rostrocaudal extent of the brain, extending through the septal area to the 
most posterior extent of the hippocampus.  
 The extent of tissue sparing following TBI was assessed blindly with respect to 
treatment group. The assessment employed an unbiased stereological protocol, the 
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Cavalieri method (Michel and Cruz-Orive 1988). A systematic random subset of sections 
from the region of interest (minimum of 12), separated by a known distance, is then 
selected for analysis. Cortical tissue sparing was measured using Image J (NIH) software. 
On each section, the total cortical area, defined as the dorsal aspect of lamina I to the 
dorsal aspect of the corpus callosum, was determined for the entire ipsilateral 
hemisphere. The cortical area of the contralateral hemisphere was also determined in an 
identical fashion using the Cavalieri method. The volume of ipsilateral tissue spared was 
compared with the volume of tissue spared contralateral to the injury, and the results 
were expressed as the percentage tissue spared [(ipsilateral/contralateral) X 100].  
 
3.3.3 Cognitive assessment 
 Two separate cohorts of animals were used for MWM testing. Cohort I involved 
NIM811 treated and vehicle treated rats (n=5/group) and only involved training. Cohort 
II included sham (n=5), NIM811 treated (n=8), and vehicle treated (n=8) rats and 
involved training and a probe trial. For training data, cohorts I and II were averaged. For 
probe data, only cohort II was used. Beginning 10 days after the injury, spatial memory 
was assessed using an adapted MWM paradigm (Morris 1984) as previously described 
(Guseva et al. 2008). The water maze was divided into four quadrants, with the platform 
submerged in one of the quadrants. Visual cues located throughout the testing room aided 
in spatial orientation. Swimming during the “transfer” trials was videotaped and 
processed using a video motion analyzer (Columbus Instruments, Columbus, OH). 
Briefly, for each trial quadrant, entry was randomized for different starting positions, and 
animals were allowed to swim until they found the platform, where they remained for 15 
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sec after the trial. If the platform was not located within the allotted 60-sec trial, the 
animal was placed on the platform for 15 sec. Each day consisted of four acquisition 
trials separated by 5-min intervals. Over 5 days a total of 20 acquisition trials were 
administered for each animal. The average time to reach the platform each day was 
calculated for individual groups. For cohort II, training was followed by one 15 sec probe 
trial. The platform was removed from the pool for the probe trial. The number of times 
each animal crossed the platform was recorded. 
 
3.3.4 Mitochondrial isolation, mitochondrial calcium buffering capacity, and 
measurement of mitochondrial function 
 All steps of the mitochondrial isolation protocol were performed on ice. At 6 h 
post-injury rats were asphyxiated with CO2 until unconscious, decapitated, and the brains 
were rapidly removed and placed in isolation buffer (215 mM mannitol, 75 mM sucrose, 
0.1% BSA, 20 mM HEPES, and 1 mM EGTA; pH 7.2). The cortices were dissected with 
a 5 mm-diameter punch centered on the site of impact. The cortical tissue punch 
contained tissue from the site of the impact and the surrounding penumbra. The tissue 
punches were homogenized and isolated by differential centrifugation as previously 
described (Singh et al. 2006). Briefly, the homogenate was centrifuged twice at 1300 xg 
for 3 min. The pellet was discarded, and the supernatant was further centrifuged at 13,000 
xg for 10 min. In order to release synaptic mitochondria, the crude mitochondrial pellet 
was subsequently subjected to nitrogen decompression using a nitrogen cell disruption 
bomb (1200 psi, 10 min). After nitrogen disruption, the mitochondria were suspended in 
3.5 mL of 15% percoll and placed on a percoll gradient consisting of 3.5 mL of 24% 
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percoll and 3.5 mL of 40% percoll in 13-mL ultraclear tubes. The gradient was 
centrifuged in a fixed-angle rotor at 30,400 xg for 10 min at 4°C. The fraction 
accumulated at the interphase of the 40% and 24% percoll layers was carefully removed 
and diluted with isolation buffer without EGTA, then centrifuged at 12,300 xg for 10 min 
at 4°C. The supernatants were carefully removed, and the pellet was resuspended in 
isolation buffer without EGTA and centrifuged at 13,000 xg for 10 min at 4°C. The 
mitochondrial pellets were recentrifuged at 10,000 xg for 5 min at 4°C to yield tighter 
pellets. The final mitochondrial pellet was resuspended in isolation buffer without EGTA 
to yield a concentration of ~10 mg/mL. The protein concentration was determined using a 
bicinchoninic acid protein assay kit (Pierce, Rockford, IL). 
 Mitochondria isolated from naïve animals were used to assess the effect of in 
vitro NIM811 treatment (1 µM) on mitochondrial Ca2+ buffering capacity and mPTP. 
Mitochondrial Ca2+ buffering capacity was assessed using a fluoresecent 
spectrofluorophotometer assay as previously described (Brown et al. 2006). 100 nM 
CaG5N (excitation, 506 nm, emission, 532 nm) was used to measure extramitochondrial 
Ca2+ in a Shimadzu RF-5301PC spectrofluorophotometer (Kyoto, Japan). Ca2+ was 
infused using a KD Scientific model 310 series infusion syringe pump (Holliston, MA) 
(160 nmol of Ca2+/mg of protein/min).  
 Mitochondrial respiration was assessed using a miniature Clark-type oxygen 
electrode (Hansatech Instruments, Norfolk, UK) in a sealed, thermostatically controlled 
chamber at 37⁰C as described previously (Patel et al. 2010; Sullivan et al. 2004). 
Mitochondrial respiration was assessed using standard polarographic methods with 
pyruvate and malate (5 and 2.5 mM, respectively) as oxidative substrates (Sullivan et al. 
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2003). Following the addition of pyruvate and malate (state II respiration), 120 nmol 
ADP was added to the chamber to induce state III respiration; this was followed by the 
addition of 1 µm oligomycin to block ATP synthesis (state IV respiration). The 
respiratory control ratio (RCR) was used as an overall metric of mitochondrial 
functionality. The RCR was calculated by dividing the slope of the response of isolated 
mitochondria to state III respiration by the slope of the response to state IV respiration. 
 
3.3.5 Mitochondrial Oxidative Damage Assessment 
 Mitochondrial lipid peroxidation was assessed as previously described by 
performing slot blots, using an antibody directed against 4-hydroxynonenonal (4-HNE) 
(Sullivan et al. 2002; Sullivan et al. 2004). Mitochondrial protein oxidation was assessed 
by measuring protein carbonyls using the OxyBlot Protein Oxidation Detection Kit 
(OxyBlot; Intergen Company, Purchase, NY) as previously described (Pandya et al. 
2007). The films were scanned and the densitometric measurements were quantified by 
outlining the reactive bands to obtain average pixel intensities, using NIH Image 
software. 
 
3.3.6 Statistical Analysis 
 For all statistical comparisons, significance was set at p ≤ 0.05. Tissue sparing 
assessment data were analyzed using a one-factor analysis of variance (ANOVA) 
followed by post-hoc analysis (Fisher PLSD test). MWM training data were analyzed 
using a two-factor repeated-measure ANOVA, with the day of training as the repeated 
measure, followed by Bonferroni post-hoc analysis. MWM probe data was analyzed by 
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one-factor ANOVA followed by SNK post-hoc analysis. Mitochondrial RCR and 
oxidative damage data were analyzed using unpaired t-tests.  
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3.3. Results 
3.3.1 Dose-response analysis of NIM811 on cortical tissue sparing following TBI 
To establish a dose-response curve for NIM811, adult rats received a severe unilateral 2-
mm cortical contusion and were administered various doses (5, 10, 20, or 40 mg/kg) of 
NIM811 or vehicle at 15 min post-injury with a subsequent injection 24 h later. In these 
experiments, cortical tissue sparing was determined at 15 days post-injury utilizing the 
Cavalieri method.  An ANOVA revealed a significant group effect in the percentage of 
the cortex damaged following TBI [F(4, 20) = 9.359; p < .0002] (Fig. 3.1). Post-hoc 
comparisons indicated that all groups administered NIM811 demonstrated significantly 
greater tissue sparing (p < 0.05) compared to vehicle-treated animals. However, animals 
receiving a 10-mg/kg dose of NIM811 demonstrated a significant (p < 0.0001) increase in 
tissue sparing compared to all other doses of NIM811.  
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Figure 3.1. NIM811 administration increases tissue sparing following TBI. Tissue 
sparing was differentially affected depending on the dose of NIM811 administered 
following a severe (2 mm) CCI TBI. Adult rats were administered various dosages of 
NIM811 (5, 10, 20, or 40 mg/kg) or vehicle at 15 min and 24 h post-injury, with 
subsequent tissue sparing assessment at 15 days post-injury. (A) Representative sections 
from a vehicle-treated animal and a 10-mg/kg NIM811-treated animal (B) Quantitative 
assessment of tissue sparing revealed that all animals receiving NIM811 demonstrated a 
significant increase in tissue sparing when compared to vehicle-treated animals. Data 
points represent group means ± SEM. #p< 0.05 vs. vehicle; @p<0.0001 vs. all other 
doses of NIM811. 
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3.3.2 NIM811 improves behavioral outcome following TBI 
 Experimental CCI TBI produces significant deficits in both acquisition and 
retention of the Morris water maze (MWM) spatial memory task (Scheff, et al., 1997). 
Spatial memory was assessed beginning 10 days post-injury using the MWM. In this 
experiment, the effect of the 10-mg/kg dose of NIM811 on MWM performance was 
compared to vehicle. NIM811 administration was associated with significant 
improvement in the acquisition phase of the MWM. ANOVA results revealed significant 
effects of the day of testing [F(4, 28) = 23.95; p < 0.0001] , treatment [F(2, 28) = 4.766; p 
= 0.0165] and a day X treatment interaction [F(8, 28) = 2.51; p=0.0152] (Fig. 3.2A). On 
day 13, post-hoc analysis of daily latencies indicated that NIM811-treated animals had 
significantly improved MWM performance compared to vehicle-treated animals (p< 
0.01). Also, on day 14 vehicle treated rats demonstrated significantly increased escape 
latency compared to sham animals (p < 0.01). During the probe trial, NIM811 treated rats 
crossed the platform significantly more times than vehicle treated animals [F(2, 20) = 
3.555; p = 0.050] (Fig. 3.2B).  No significant group differences in swim speed were 
present during the acquisition phase of testing (data not shown). 
 
 
 
                   
56 
 
 
Figure 3.2. NIM811 treatment improves MWM performance following TBI. (A) Animals 
that received 10 mg/kg of NIM811 (15 min and 24 h post-injury) (triangles) found the 
submerged platform significantly faster on day 13 than vehicle-treated animals (squares). 
(B) Number of platform crossings over the 15 sec memory retention test. Vehicle treated 
animals significantly found the platform fewer times than sham animals; NIM811 
treatment attenuated this deficit in memory retention. Data points represent group means 
± SEM. *p<0.01 vs. sham and NIM811; #p<0.01 vs. sham, @p<0.05 vs. sham. 
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3.3.3 NIM811 attenuates post-traumatic mitochondrial dysfunction and oxidative damage 
 The ability of NIM811 to inhibit mPTP in isolated mitochondria from naïve 
animals was assessed using a calcium infusion assay. In vitro treatment of naïve 
mitochondria with NIM811 indicated that NIM811 increases the Ca2+ buffering capacity 
of isolated mitochondria and delays the onset of mPTP compared to vehicle treatment 
(Fig. 3.3A). In order to elucidate the effects of NIM811 administration on mitochondrial 
bioenergetic function, mitochondria were isolated at 6 h post-injury from the ipsilateral 
hemisphere of animals administered NIM811 (10 mg/kg) or vehicle at 15 min post-
injury. Mitochondrial respiration was measured using a Clark-type oxygen electrode. 
Respiratory control ratios (RCR) were used as a metric for overall mitochondrial 
functionality. RCR values (state III/state IV) represent the extent of coupling between 
proton transport and ATP production. As expected, vehicle-treated rats showed 
significantly lower RCR values (3.06 ± 0.18) than NIM811-treated rats (5.65 ± 0.27) (p < 
0.0001) following TBI (Fig. 3.3B).   
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Fig. 3.3. NIM811 is a potent inhibitor of mPTP and NIM811 treatment attenuates injury-
induced impairments in mitochondrial bioenergetics following TBI. (A) Representative 
Ca2+ infusion traces from isolated naïve mitochondria in the presence and absence of 
NIM811 (1 µM). In the presence of NIM811, mitochondria buffered more of the infused 
Ca2+ than in the absence of NIM811. Animals were subjected to a severe CCI TBI and 
administered the optimal dose of NIM811 (10 mg/kg) or vehicle at 15 min post-injury. 
(B) At 6 h post-injury, NIM811-treated rats demonstrated significantly higher RCRs than 
vehicle-treated rats, indicating that coupling of the electron transport system to oxidative 
phosphorylation was maintained. Bars are group means ± SEM. @p<0.0001 vs. vehicle. 
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 Mitochondrial oxidative stress and deficits in mitochondrial functioning have 
been shown to occur simultaneously following experimental TBI (Opii, et al., 2007, 
Singh, et al., 2006). In order to determine the effects of NIM811 treatment on 
mitochondrial oxidative damage, a portion of the mitochondria isolated from the 
ipsilateral cortex were used for quantitative measurement of 4-HNE, as an index of lipid 
peroxidation, and protein carbonyls, as an index of protein oxidation, using slot blots and 
OxyBlots, respectively. Analysis of oxidative damage markers at 6 h post-injury 
demonstrated that mitochondria isolated from NIM811-treated rats had significantly 
lower levels of 4-HNE (p < 0.01) and protein carbonyls (p < 0.02) (Fig. 3.4).  These data 
indicate that treatment with NIM811 attenuates TBI-induced mitochondrial oxidative 
damage. 
 
 
 
  
60 
 
 
 
 
Figure 3.4. Administration of NIM811 (10 mg/kg) reduces mitochondrial oxidative 
damage following TBI. NIM811 administration significantly decreased levels of 
mitochondrial (A) lipid peroxidation and (B) protein carbonyls at 6 h post-injury. Bars 
are group means ± SEM. #p<0.05 vs. vehicle.  
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3.4 Discussion 
 Following TBI, mitochondrial dysfunction precedes secondary cell death 
(Robertson 2004). The overall hypothesis for the current study was that attenuation of 
this dysfunction with NIM811 would result in neuroprotection. In the present study, 
NIM811, which inhibits mPTP without affecting calcineurin, significantly increased 
tissue sparing when compared to vehicle-treated animals. The dose-response of NIM811 
is an inverted U-shaped curve, with 10 mg/kg as the most effective dose. The 10-mg/kg 
dose of NIM811 was selected as the optimal dose based on these results and is in line 
with a previous report of Mbye and colleagues (Mbye et al. 2008).  
 Human TBI results in significant memory dysfunction and potential TBI 
therapeutics should be aimed at attenuating this common clinical observation. The 
neuroprotective efficacy of NIM811 has been recently demonstrated following severe 
TBI. However, prior to the current study the neuroprotective effects of NIM811 had yet 
to be translated into improved cognitive endpoints.  In the present study we determined if 
the neuroprotective effects of NIM811 would translate into significant improvements in 
MWM performance. Indeed the neuroprotection provided by the 10-mg/kg dose of 
NIM811 translated into a significant reduction in brain injury-induced spatial learning 
deficits in the acquisition phase and memory phase of the MWM. While there was a 
general trend of NIM811 improving memory on every day of training, only on day 13 did 
NIM811 treatment significantly decrease escape latency compared to vehicle treatment. 
Also, on day 14 of training vehicle treated rats had significantly increased escape 
latencies compared to sham animals (on day 14 NIM811 treated animals were not 
significantly different than sham).   During the probe trial on average approximately 3 out 
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4 NIM811 treated animal crossed the platform at least once, whereas only 1 in 4 vehicle 
treated animals crossed the platform.  
 Since mitochondrial dysfunction occurs as early as 15-30 min post-injury, it has 
been suggested that therapeutic interventions targeting mitochondria must be initiated 
early after TBI (Gilmer et al. 2009; Singh et al. 2006; Sullivan et al. 1998). In previous 
studies, mice showed a significant improvement in mitochondrial function following a 
single IP injection of NIM811 administered 15 min post-injury. Based on these findings, 
it was determined that a single injection at 15 min post-injury may be sufficient to 
attenuate the rapid mitochondrial dysfunction occurring following TBI.  Based on our 
dose-response studies, we decided to investigate the effects of treatment with the 10-
mg/kg dose of NIM811 on mitochondrial respiration compared to vehicle. We chose to 
evaluate the effect of NIM811 or vehicle at 6 h post-injury based on previous studies 
showing that mitochondrial dysfunction peaks between 6 and 12 h post-injury (Singh et 
al. 2006; Xiong et al. 2007). Results from our mitochondrial studies indicated that 10 
mg/kg of NIM811 was effective in attenuating trauma-induced mitochondrial dysfunction 
compared to vehicle treatment. This improvement in mitochondrial function most likely 
represents maintained mitochondrial electron transport as a result of NIM811-mediated 
inhibition of mPTP formation (Sullivan et al. 1999). 
 Although the mechanisms of secondary injury are not completely understood, 
increased free radical generation post-TBI and subsequent lipid peroxidation and protein 
nitration appear to play a role in the progressive neuropathology associated with TBI 
(Deng-Bryant et al. 2008; Deng et al. 2007; McCall et al. 1987; Readnower et al. 2010; 
Singh et al. 2006). mPTP formation and mitochondrial oxidative damage occur 
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simultaneously following TBI (Sullivan et al. 2005). Here, we demonstrate that a 10-
mg/kg dose of NIM811 significantly reduced levels of protein oxidation and lipid 
peroxidation in rats following TBI. These findings are in line with the results observed in 
mice by Mbye and colleagues (Mbye et al. 2008). Because NIM811 and CsA lack the 
chemical structure to act as direct antioxidants or free radical scavengers, the reduction in 
oxidative damage is most likely an indirect effect of maintained mitochondrial 
homeostasis, which would result in fewer free radicals and less oxidative damage (Mbye, 
et al., 2008).  
 It is well established that Ca2+ increases mitochondrial ROS production; however, 
the mechanism through which Ca2+ induces ROS formation is largely unknown (Komary 
et al. 2010; Votyakova and Reynolds 2005). Since mPTP decreases mitochondrial Ca2+ 
levels, it may be hypothesized that inhibition of mPTP would increase mitochondrial 
ROS production. But, here, we show that mPTP inhibition actually decreases 
mitochondrial oxidative stress. This finding may be explained by two possible 
mechanisms: (i) mPTP formation results in inner membrane structural alterations leading 
to increased ROS production or (ii) mPTP results in decreased clearance of ROS due to 
impairment of antioxidant systems (Crompton 1999; Kowaltowski et al. 1995). In 
isolated mitochondria, mPTP formation increases mitochondrial ROS production, and 
inhibition of mPTP with CsA decreases ROS production (Maciel et al. 2001). These 
findings suggest that the mechanism by which mitochondrial Ca2+ uptake promotes ROS 
production is actually mediated through mPTP formation.  This notion is supported by 
the findings that Ca2+ does not increase ROS production without mPTP formation 
(Hansson et al. 2008). 
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 The clinical utility of Cyp-D inhibitors, such as NIM811 and CsA, may be limited 
by the overall role mPTP plays in both apoptosis and necrosis. In studies involving Cyp-
D knockout mice, Ca2+  and oxidative stress insults required mPTP for induction of cell 
death while Bcl-2 mediated cell death did not require mPTP (Baines et al. 2005).  Taken 
together this may indicate that mPTP inhibition itself may not overcome all cell death 
pathways initiated by the mitochondria. 
 To date, the efficacy of NIM811 has been demonstrated in multiple models of 
neurodegeneration, including transient focal cerebral ischemia, spinal cord injury, and 
TBI (Korde et al. 2007; Mbye et al. 2009; Mbye et al. 2008; McEwen et al. 2007; 
Ravikumar et al. 2007). Despite the proven efficacy of CsA, NIM811 may have better 
potential as a TBI therapeutic due to its reduced toxicity and specificity as a mPTP 
inhibitor relative to CsA (Mazzeo et al. 2009). The substitution of isoleucine for leucine 
at the fourth amino acid of CsA allows NIM811 to bind CyP-D and cyclophilin A (CyP-
A) but prevents NIM811 from inhibiting calcineurin. Like other cyclophilins, CyP-A 
exhibits peptidylprolyl isomerase (PPIase) activity which is  associated with chaperone-
like actions which aid in de novo protein folding and protein repair/refolding following 
stress (Andreeva et al. 1999). This PPIase activity may be especially important following 
brain injury and may aid in recovery. One recent study demonstrated that Cyp-A protein 
expression was increased following CCI TBI and that exogenous administration of CyP-
A following a stab wound decreased blood-brain barrier permeability and reduced tissue 
damage (Redell et al. 2007). Our observed U-shaped dose-response could reflect this; 
although inhibition of mPTP with 10 mg/kg of NIM811 was protective, perhaps the 
higher doses became cytotoxic due to further inhibition of other cyclophilin family 
65 
 
members, which indicates isoform-specific cyclophilin inhibitors may provide even 
greater neuroprotection than either CsA or NIM811. Nevertheless, the current data 
supports the involvement of the mPTP in TBI neuropathology and validates mPTP 
inhibition as a potential neuroprotective target for TBI. 
 In summary, 10 mg/kg of NIM811 is the most effective dose for achieving 
neuroprotection following TBI. NIM811 treatment is capable of improving mitochondrial 
function and reducing mitochondrial oxidative stress when compared to vehicle treatment 
following TBI. This is one of the first studies demonstrating that mPTP inhibition 
following TBI can be directly translated into improved cognitive behavior. These data 
highlight the importance of maintaining mitochondrial homeostasis following TBI. Since 
NIM811 is less toxic than CsA, it may be administered at higher doses which may confer 
a greater degree of neuroprotection following trauma. 
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4. CHAPTER 4 
Increase in Blood–Brain Barrier Permeability, Oxidative Stress, and Activated 
Microglia in a Rat Model of Blast-Induced Traumatic Brain Injury 
(Published in Journal of Neuroscience Research, 88, 3530-3539) 
4.1 Introduction 
 Accumulating clinical evidence as well as experience in contemporary military 
operations suggests that substantial short-term and long-term neurologic deficits can be 
caused by blast exposure without a direct blow to the head (Cernak et al. 1999; DePalma 
et al. 2005; Elder and Cristian 2009; Ling et al. 2009; Trudeau et al. 1998). With an 
estimated 15% of troops serving in Iraq sustaining some level of neurological impairment 
due to blast exposure, TBI has become the signature injury of this war (Hoge et al. 2008). 
Hoge and colleagues reported a high correlation between service members who reported 
symptoms consistent with mild TBI and those who received exposure to blast. Although 
sharing common clinical features with both, brain injury caused by blast (bTBI) is 
clinically distinct from closed head and/or penetrating TBI (Ling et al., 2009). While the 
exact biophysics underlying bTBI are not completely understood, interaction with a fast 
moving, transient pressure wave is generally accepted as the primary cause of brain 
injury that results from blast exposure (DePalma et al. 2005; Elsayed 1997; Taber et al. 
2006). Experimental studies in rodents have demonstrated a correlation between memory 
dysfunction and distribution of neuropathological damage in the brain after exposure to 
blast overpressure (BOP) (Cernak et al. 2001a; Cernak et al. 2001b).  
Previous studies have also demonstrated that rats exposed to low and moderate 
intensity BOP (83 kPa or 112 kPa) had lowered food intake and exercise performance 
(Bauman et al. 1997) with similar findings being reported in sheep (Mundie et al. 2000). 
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Rats exposed to low intensity BOP (20 kPa) displayed significant performance deficits on 
rotametric and grip-strength tests (Moochhala et al. 2004; Saljo et al. 2009b) whereas 
animal studies using moderate levels of BOP (126 kPa) have shown Morris water maze 
performance impairment, gliosis, and fiber degeneration (Long et al. 2009). Reactive 
gliosis, neuronal swelling, and cytoplasmic vacuolation have also been observed in the 
hippocampus of rats subjected to thoracic blast injury (Cernak et al. 2001b). Rhesus 
monkeys exposed to high BOP (207 kPa, 276 kPa, or 345 kPa) demonstrated significant, 
albeit transient, memory and performance deficits (Bogo et al., 1971).  
 TBI can result in brain microvasculature and blood-brain barrier (BBB) 
breakdown leading to increased BBB permeability. Disruption of the BBB following TBI 
results in brain edema, a primary event that affects both morbidity and mortality 
following TBI (Unterberg et al. 2004). Edema increases intracerebral pressure (ICP), and 
leads to secondary ischemic injuries by impairing cerebral perfusion and oxygenation 
(Unterberg et al., 2004). Following TBI, various mediators are released which enhance 
vasogenic and/or cytotoxic brain edema. These include glutamate, lactate, H+, K+, Ca2+, 
nitric oxide, arachidonic acid and its metabolites, free oxygen radicals, histamine, and 
kinins (Unterberg et al., 2004). BBB permeability to endogenous proteins, such as 
immunoglobulins (IgG), is increased following experimental TBI (Sullivan et al. 2000b; 
Tanno et al. 1992). An additional consequence of BBB disruption is the infiltration of 
leukocytes into brain tissue, activation of microglia and inflammation (Morganti-
Kossmann et al. 2007). There is some indication of a widespread activation of microglia 
1-14 days after exposure to blast, however, it remains unclear if this activation was a 
direct result of blast wave or it was caused indirectly by an increase in permeability in 
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blood-brain barrier and transfer of inflammatory mediators from circulation (Kaur et al. 
1995). Oxidative stress has been shown to play a critical role in the secondary injury 
process following TBI. In recent work, our colleagues demonstrated that following both 
controlled cortical impact and weight drop models of TBI there is a rapid increase in the 
lipid peroxidation marker, 4-hydroxynonenal (4-HNE), and protein nitration marker, 3-
nitrotyrosine (3-NT) (<30 min post injury), which returned to control levels 24 h post-
injury (Deng et al. 2007; Hall et al. 2004).   
  PK11195, an isoquinoline derivative, is an antagonist of the translocator 
protein (TPSO) (18 kDa) (Banati et al., 1997). TPSOs, previously referred to as the 
peripheral benzodiazepine receptor (PBR), play an important role in steriodogenesis by 
acting as cholesterol pores in the outer mitochondrial membrane (Scarf et al. 2009). 
TPSOs are absent from neurons but are expressed in high density in glial and ependymal 
cells (Chen and Guilarte 2008). Increased PK11195 binding has been localized to 
activated microglia in several animal models of CNS injury including TBI, ischemia, and 
excitotoxic lesion models (Dubois et al. 1988; Gotti et al. 1990; Grossman et al. 2003). 
The use of TPSO autoradiographic analysis as a marker of inflammation is advantageous 
over other methods due to the high sensitivity and anatomical resolution of the technique 
(Benavides et al. 2001).      
  To begin to elucidate the mechanism(s) involved in bTBI neuropathology the 
current study was designed to assess acute changes in neurological function and to 
characterize acute changes in BBB permeability and oxidative damage, and the subacute 
inflammatory response of the brain following BOP exposure. The results demonstrate the 
novel findings that following exposure to a moderate BOP (120 kPa) there is significant 
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reflex suppression, disruption of the BBB, oxidative stress, and widespread microglia 
activation. Taken together, these data suggest that bTBI shares mechanisms of 
pathobiology that are hallmarks of injury in other models of TBI, which may widen 
future avenues of neuroprotective interventions for blast injuries.     
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4.2 Methods 
4.2.1 Animals and exposure to blast 
 Adult virus-free male Sprague-Dawley rats (250 - 300 g; n = 49) were randomly 
divided into blast-exposed (n = 44) and control group (n = 14). Animals were 
anesthetized with isoflurane and positioned in a holder that prevented secondary and 
tertiary blast injuries as previously described (Chavko et al. 2006). Animals were then 
placed into the end of the expansion chamber of an air-driven shock tube (2.5 ft 
compression chamber connected to a 15 ft expansion chamber) with their right side 
ipsilateral to the direction of the BOP. Animals assigned to exposures were subjected to a 
peak overpressure of 120 kPa. Control animals received anesthesia and were treated in 
the same way except for the exposure to BOP. 
 
4.2.2 Acute Neurological Assessment  
 Acute neurological function was assessed using a battery of tests that are 
analogous to motor components of the Glasgow Coma Scale (GCS) as previously 
described (Dixon et al. 1987). These tests measure the duration of suppression of a 
response due to injury. Immediately following BOP exposure or control treatment, the 
duration of suppression of three reflexes were acutely evaluated. The reflexes of control 
animals were evaluated in order to determine the effects of anesthesia on reflex 
suppression. The corneal reflex was assessed by lightly touching the eye to elicit a 
blinking response. The paw flexion reflex was assessed by briefly applying a pinch 
(approximately 0.2 kg/mm2) to the hind paw to elicit a withdrawal response. The righting 
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response was tested by placing the animal on its back and timing the return to a 
spontaneous upright position. Evaluation continued until all reflexes had returned.  
 
4.2.3 Immunohistochemistry 
 For IgG immunohistochemical assessment a total of 24 animals were exposed to 
blast   and  allowed to recover for either 0.5, 3, 24, or 72 hours following BOP exposure 
(n=6/group).  A total of 6 control animals were handled in a similar manner and did not 
receive any BOP exposure. At the designated survival intervals animals were 
anesthetized with pentobarbital (95 mg/kg body weight) and transcardially perfused with 
phosphate buffered saline (PBS) followed by 4 % paraformaldehyde, pH 7.4. After 
removal, the brains were placed in 4 % paraformaldehyde-sucrose (15%) for an 
additional 24 hrs. Coronal sections (50 μm) were then cut using a freezing microtome 
throughout the rostral caudal extent of the brain, extending through the septal area to the 
most posterior extent of the hippocampus. BBB permeability was assayed on every 
twelfth section from each animal with biotinylated anti-rat IgG antibody as previously 
described (Hoane et al. 2006). Sections were rinsed with PBS and incubated in 0.3% 
H2O2 in order to block endogenous peroxidase activity. Next sections were blocked in 
10% normal goat serum with 0.2% Triton X-100 in PBS for 1 h at room temperature 
followed by incubation in primary antibody overnight at 4⁰C (1:1000; biotinylated goat 
anti-rat IgG, Vector Labs, Burlingame, CA). Sections were rinsed and incubated in 
avidin-horseradish peroxidase complex (Vectastain ABC, Burlingame, CA) for 1 hour.  
IgG immunoreactivity was visualized by incubation of sections in 0.05% 
diaminobenzidine, 0.01% H202, and 0.3% imidazole for 10 minutes. Lastly, sections were 
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rinsed with PBS, mounted on gelatinized slides, and coverslipped with permount. IgG 
immunoreactivity was quantified using a gray-level-index (GLI) as previously described 
(Bisler et al. 2002). Quantification was performed using Image-Pro Plus software 
(Mediacybernetics, Bethesda, MD) such that GLI values corresponded to the area of 
immunoreactivity in relation to an area of interest. The GLI value for each section (~12 
sections per animal) were calculated and averaged in order to determine the percent total 
brain area immunoreactive for IgG. These values were then averaged for each group. 
 For immunohistochemical detection of brain oxidative stress levels a total of 6 
animals were subjected to BOP and allowed to recover for either 3 h or 24 h following 
BOP exposure. A total of 3 control animals were handled in a similar manner and did not 
receive any BOP exposure. At the designated survival intervals animals were 
anesthetized with pentobarbital and perfused with PBS and 4 % paraformaldehyde. 
Brains were placed in 4 % paraformaldehyde-sucrose (15%) for an additional 24 hrs. 
Coronal sections (50 μm) were then cut using a freezing microtome throughout the rostral 
caudal extent of the brain, extending through the septal area to the most posterior extent 
of the hippocampus. Free floating sections were double-labeled for 3-NT (1:1000; mouse 
anti-3NT monoclonal antibody, Upstate, Lake Placid, NY) and 4-HNE (1:5000; rabbit 
anti-HNE polyclonal antibody, Calbiochem, San Diego, CA) and visualized by infrared 
immunohistochemistry as previously described with few modifications (Hawes et. al., 
2005). Briefly, sections were washed three times for 5 min each in PBS, followed by 
adduct reduction in 0.1 M NaBH4 in 0.1 MOPS (Sigma) for 10 min. Following reduction 
sections were rinsed three times for 5 min each in PBS, followed by blocking in 10% 
normal goat serum with 0.2% Triton X-100 in PBS for 1 hour at room temperature. 
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Sections were incubated in primary antibodies overnight at 4⁰C. Before incubation in 
secondary antibody, sections were washed three times for 5 min each in PBS. Sections 
were then incubated with secondary antibodies for 2 h at room temperature (1:20,000; 
IRDye700DX conjugated anti-mouse IgG; Gilbertsville, PA) (1:10,000; IRDye800 
conjugated anti-rabbit IgG; Gilbertsville, PA). All sections were rinsed three times for 5 
min each in PBS and mounted onto Fisher Superfrost Plus Slides. Slides were scanned 
simultaneously on a LICOR Odyssey Infrared Imager (LI-COR Biosciences). The 
fluorescence intensity for each section (~12 sections per animal) was quantified using an 
area of similar size throughout each section. In order to obtain a value for each animal the 
levels of 3-NT and 4-HNE for each section were averaged. These values were then 
averaged for each group. 
 For assessment of microglia morphology antibodies against CD11b/c that 
recognize microglia-specific complement type 3 receptor were utilized. Briefly, 
endogenous peroxidase activity was blocked using 0.3% H2O2. Next sections were 
blocked in 10% normal goat serum with 0.2% Triton X-100 in PBS for 1 h at room 
temperature followed by incubation in primary antibody overnight at 4⁰C (1:1000; mouse 
anti-rat CD11b/c; BD Pharmigen, San Diego, CA). Sections were then incubated in 
secondary antibody for 2 h at room temperature (1:500; biotinylated goat anti-mouse; 
Vector Laboratories, Burlingame, CA). Sections were rinsed and incubated in avidin-
horseradish peroxidase complex (Vectastain ABC, Burlingame, CA) for 1 hour.  IgG 
immunoreactivity was visualized by incubation of sections in 0.05% diaminobenzidine, 
0.01% H202, and 0.3% imidazole for 10 minutes. Lastly, sections were rinsed with PBS, 
mounted on gelatinized slides, and coverslipped with permount. 
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4.2.4 [3H]PK11195 Autoradiography 
 For autoradiography studies a total of 14 animals were subjected to BOP and 
allowed to recover for either 5 or 10 days following exposure (n=7/group). A total of 5 
control animals were given the same treatment except for BOP exposure. Animals were 
euthanized and their brains were immediately removed and frozen in isopentane on dry 
ice. Brains were sectioned (16 µm) on a cryostat and mounted on Fisher Superfrost Plus 
Slides. TPSO autoradiography was performed using 1 nM [3H]PK11195 ligand 
(PerkinElmer, Boston, MA, specific activity=85.5Ci/mmol) as previously described 
(Kelso et al., 2009). Brain sections were preincubated in 50 mM Tris- HCl, pH 7.4 at 4⁰C 
for 15 minutes, followed by incubation with radioactive ligand at 4⁰C for 2 hours. The 
binding was terminated by washing sections in 50 mM Tris- HCl, pH 7.4 (3 x 3 min), 
followed by dipping in ice cold water. The sections were exposed to Kodax BioMax 
Autoradiography Film (Kodak, Rochester, NY) for 55 days. All films were developed 
using a Kodak D-19 developer and analyzed using NIH image v1.59 on a Power 
Macintosh connected to a Sony XC-77 CCD camera via a Scion LG-3 frame-grabber 
(Scion, Inc., Frederick, MD).  Autoradiograph data was quantified by densitometry.   
 
4.2.5 Statistics 
 Individual reflexes (corneal, paw flexion, and righting) were analyzed by one-
tailed t-test. Data from immunohistochemical assays were analyzed by one-way ANOVA 
followed by Student Newman-Keuls (SNK) post-hoc analysis. [3H]PK11195 
autoradiography results were analyzed by two-way repeated measures (hemisphere) 
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ANOVA followed by Bonferroni post-hoc analysis. Significance was accepted as p<0.05. 
All values are presented as means ± SEM. 
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4.3 Results 
4.3.1 Effect of blast overpressure on acute neurological function and brain morphology 
Recently Hamm (2001) demonstrated that reflex suppression is a sensitive predictor of 
injury effect, therefore acute neurological deficits as a result of BOP exposure were 
assessed using a battery of reflexes which test somatomotor function (Hamm 2001). The 
survival rate of animals following BOP exposure was 98%. The return of the corneal 
reflex in BOP exposed animals (23.6 ± 2.2 sec) was significantly delayed compared to 
control animals (14.33 ± 6.6 sec) (p<0.05). Additionally, BOP exposure resulted in a 
significant suppression of the paw flexion reflex (47.7 ± 4.0 sec) compared to control 
animals (21.8 ± 4.5 sec) (p<0.01) (Fig. 4.1). However, no significant differences were 
measured between the righting reflexes of either group. There was no evidence of tissue 
disruption or tissue loss in BOP exposed animals (Fig. 4.2). 
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Figure 4.1. Effect of BOP on acute neurological functioning immediately following 
exposure. Exposure to blast (full columns) significantly delayed the return of corneal and 
paw flexion reflexes compared to control (open columns). The data represents the mean 
duration of suppression ± SEM. Significance (t-test) is denoted as follows: #p<0.05, 
*p<0.01 vs. control. 
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Figure 4.2.  Representative images of H & E stained brain sections of control (A) and at 
3 days post blast 120 kPa (B). There were no overt signs of tissue disruption or cell loss. 
Scale bar denotes 1 mm. 
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4.3.2 Effect of blast overpressure on IgG immunoreactivity  
The spatial extravasation of endogenous IgG immunoreactivity was used as an index for 
BBB breakdown following BOP exposure. BBB disruption is a well-established hallmark 
following brain injury and has been assessed in several models of TBI. Qualitative 
assessment of IgG extravasation revealed that at 3 and 24 h following BOP exposure 
there was a conspicuous increase in IgG immunoreactivity in the outer most layer of the 
cortex. An ANOVA revealed a significant group difference (F[4,22]= 12.77, p<0.0001) 
in IgG immunoreactivity following BOP exposure. Following BOP exposure, post-hoc 
comparisons revealed a significant increase in IgG immunoreactivity at 3 (p<0.001) and 
24 h (p<0.01) post BOP exposure (Fig. 4.3 & 4.4). Although not significant there was a 
trend towards increased IgG immunoreactivity at 0.5 h post injury surrounding the lateral 
ventricles. 
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Figure 4.3. Effect of 120 kPa BOP on brain IgG immunoreactivity. The images are 
representative for A - Control animals; B - 0.5 h post blast; C - 3 h post blast; D - 24 h 
post blast; E - 3 days post blast. Increased IgG immunoreactivity in layer I of the cortex 
was observed at 3 and 24 h following exposure. Although not significant there was 
increased staining in the area surrounding the lateral ventricles (4 out of 6 brains) at 0.5 h 
post blast. There was no difference in IgG staining in brains 3 days post exposure 
compared with controls. Scale bar denotes 1 mm. 
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Figure 4.4. Quantification of IgG immunoreactivity in brain sections after exposure to 
blast. Significant increases in IgG staining were observed at 3 and 24 h after exposure 
compared to control. The data represents the percentage of brain area stained for IgG  ± 
SEM. Significance with ANOVA followed by post hoc analysis (SNK) as follows: 
*p<0.01 vs. control; #p<0.05 vs. 72 hr.  
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4.3.3 Effect of blast overpressure on oxidative stress 
Oxidative stress is known to play a role in the secondary injury cascade following TBI; in 
the present study we determined 3-NT and 4-HNE levels following BOP exposure using 
quantitative immunohistochemistry. An ANOVA revealed a significant group difference 
(F[2,6]= 11.24, p<0.01) in 4-HNE levels following BOP exposure at 3 h post-exposure 
(p<0.01). 4-HNE levels returned to control values at 24 h post-exposure. Similarly, there 
was a significant group difference (F[2,6]= 11.55, p<0.01) in 3-NT levels at 3 h 
following exposure (p<0.05) which returned  to control values at 24 h post-exposure (Fig. 
4.5).  
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Figure 4.5. Quantification of 4HNE (A) and 3NT (B) levels in brain sections after 
exposure to blast. Significant increases in 3NT and 4HNE levels were observed at 3 h 
after exposure compared to control. At 24 h after exposure, 3 NT and 4HNE levels 
returned to control values. The data represents the mean fluorescence ± SEM. 
Significance with ANOVA followed by post hoc analysis (SNK) as follows: *p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
84 
 
4.3.4 Effect of blast overpressure on TPSO binding and microglia morphology 
Inflammation has been demonstrated in multiple models of TBI; in the present study 
microglial activation was determined using TPSO autoradiographic localization. The 
effects of blast exposure on TPSO density were evaluated using [3H]PK11195 
autoradiography in several brain regions at 5 and 10 days post blast (Fig. 4.6). A two-way 
ANOVA was significant for effect of BOP exposure (F[2, 16] = 2.287, p<0.001), but not 
for hemisphere (F[1, 16] = 11.20, p>0.05) (Table 4.1). No significant interaction between 
BOP exposure and hemisphere existed (F[2, 16] = 1.494, p>0.05). At 5 days post blast, 
post-hoc testing revealed a significant increase in the density of [3H]PK11195 binding in 
the ipsilateral dentate gyrus (p<0.001) and contralateral dentate gyrus (p<0.05). At 10 
days post blast, post-hoc comparisons revealed a significant increase in [3H]PK11195 
binding in the contralateral dentate gyrus (p<0.001), ipsilateral dentate gyrus (p<0.001), 
contralateral substantia nigra (p<0.01), and contralateral ventral hippocampus (p<0.05).   
 In order to further demonstrate the response of microglia to BOP exposure 
antibodies against CD11b/c were used to visualize microglia morphology. In the cortex, 
hippocampus, and substantia nigra of control animals microglia demonstrated a resting 
morphology characterized by highly ramified processes (Fig. 4.7). In contrast microglia 
in the hippocampus from animals exposed to blast displayed an activated morphology 
characterized by clustering. In addition to this microglia in the substantia nigra of BOP 
exposed animals revealed activated morphology characterized by rounded cell bodies and 
fewer ramifications. 
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Figure 4.6. Effect of exposure to 120 kPa BOP on TPSO expression. Pseudocolored 
autoradiogram of brain sections labeled with [3H]PK11195 in control and in 5 or 10 days 
post exposure animals. Four different levels are shown: A - anterior striatum; B - dorsal 
hippocampus; C - dorsolateral thalamus; D - ventral hippocampus. Brain regions 
abreviated as follows: primary motor cortex (M1), striatum (St), dentate gyrus (DG), 
dorsolateral thalamus (DT), ventral hippocampus (VH), and substantia nigra (SN). 
Prominent areas of high TPSO density in control animals are restricted to 
ventricular/choroid plexus regions. High density areas of TPSO in exposed animals are 
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the dentate gyrus and substantia nigra. The scale shown at bottom shows the range from 
low to high expression.     
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                        Table 4.1. Q
uantification of TPSO
 expression in selected brain regions. There w
as a significant increase in PK
11195 binding 
in the dentate gyrus at both survival intervals. In addition the TPSO
 expression w
as increased in both the contralateral 
substantia nigra and ventral hippocam
pus 10 days after blast. The data represents the m
ean density of [ 3H
]PK
11195 binding 
(arbitrary optical units) ± SEM
.  Significance from
 control is denoted as follow
s: *p<0.001; **p<0.05. 
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Figure 4.7. Effect of 120 kPa BOP on microglia morphology in selected brain loci. In 
order to confirm PK11195 autoradiographic data demonstrating microglial activation in 
the dentate gyrus and substantia nigra, antibodies against CD11b/c were employed to 
visualize microglial morphology. In sham animals all regions that were evaluated 
contained microglia with resting morphology characterized by highly ramified processes 
(A-C). In the cortex of animals exposed to blast microglia also displayed resting 
morphology (D). Exposure to blast resulted in activated microglial morphology 
characterized by microglial clustering in the hippocampus (dentate gyrus, E). In addition 
activated microglia morphology in the substantia nigra is revealed by microglia with 
rounded cell bodies and reduced ramifications (F). Scale bar = 50 µm. 
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4.4 Discussion 
 Brain injury in rats as a result of exposure to BOP using an air-driven shock tube 
was used to study the progression of neuropathological processes that could be relevant 
to blast exposed populations. The systemic effects of the level of blast (~120 kPa) used in 
the present study were previously characterized and it was shown to induce moderate 
pulmonary damage with an acute inflammatory responses that were resolved by 8 days 
(Chavko et al., 2006). The exposure to this level of BOP does not produce lethal damage 
and the survival rate of rats at 120 kPa under isoflurane anesthesia is more than 90%.  In 
the present study we looked for some basic neurological and neuropathological changes 
in the brain and demonstrated that 120 kPa BOP exposure produced acute reflex 
suppression in rats which was similar to suppression observed in other models of diffuse 
brain injury (Denny-Brown and Russell 1940; Dixon et al. 1987; Fijalkowski et al. 2007). 
This extent of reflex suppression is consistent with concussion and mild TBI which 
closely resembles the clinical manifestation of bTBI (Bruns and Jagoda 2009; Jones et al. 
2007). Previous studies have demonstrated a dose response relationship between the 
extent of acute neurological impairment and overall cognitive outcome following 
experimental diffuse brain injury (Beaumont et al. 1999). Long and colleagues (2009) 
reported that following 126 kPa BOP exposure there is transient cognitive dysfunction; 
the observed reflex suppression in the present study predicts these findings by Long. The 
results also demonstrate increased IgG immunoreactivity in the brain 3 and 24 h after 
exposure indicating increased early permeability of BBB followed by microglia 
activation at 5 and10 days post-exposures.  
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  BBB breakdown has been shown to occur early after TBI; it is mostly transient 
and the time course of the BBB opening varies in different models. In a fluid percussion 
model of injury, BBB damage in the rat brain was most pronounced within the first hour 
after TBI and was reestablished by 6 h after injury (Tanno et al. 1992). Others also 
reported that the BBB sealed within a few hours after fluid-percussion injury (Enters et 
al. 1992). We observed significant BBB breakdown following blast which was limited to 
layer I of the cortex and was considerably smaller in comparison to diffuse fluid 
percussion brain injury, where overt BBB breakdown was observed throughout the 
neocortex, hippocampus, and thalamus (Kelley et al. 2007). Similarly to other TBI 
models BBB disruption was transient and appeared recovered by 3 days.  
 It is generally thought that the BBB opening is a major factor contributing to the 
presence of brain edema observed in TBI. However, in some TBI models, edema 
formation clearly does not correspond with BBB opening (Beaumont et al. 2000). 
Instead, cytotoxic mechanism is thought as the major mechanism of edema formation in 
TBI. Despite this a permeable BBB can provide a route for passive fluid movement and 
thus worsening the cytotoxic cell edema.   Recently, Saljo et al (2009) reported a blast 
dose-dependent rise in ICP in rats exposed repetitively 3 times to blast, and an increasing 
time delay in elevation with decreasing intensity of exposure. While the initial elevation 
took place within 30 min after exposure to 60 kPa, it did not appear until after 2 h and 6 h 
after exposure at 30 and 10 kPa, respectively. The delayed BBB opening and similar time 
course in ICP increase may indicate a contribution of vasogenic component to brain 
damage after exposure to blast.  
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 BBB breakdown in TBI can be a result from the initial insult or the product of 
secondary injuries, such as accumulation of inflammatory cytokines.  Whalen et al. 
(1997) found a pattern of transient BBB opening that was independent of inflammation; 
the BBB was leaky within the first 30 minutes to 4 hours after controlled cortical impact 
in rats whereas white blood cell accumulation peaked at 24 hours (Whalen et al. 2000). It 
was concluded that BBB damage was not related to the white blood cell accumulation 
and inflammation. It was previously shown that exposure to BOP produced early (1-3 h 
post exposure) recruitment of polymorphonuclear leukocytes (PMNs) in peripheral blood 
at the level of blast in the present study (Gorbunov et al. 2004). Therefore, contribution of 
inflammation to the BBB opening cannot be ruled out and needs further investigation.  
 In virtually all pathological conditions of the CNS, accumulation and activation of 
microglia precedes or is concomitant to neuronal and glial cell damage. Microglia as the 
principal immune cells in the CNS are known as a source of  highly cytotoxic substances 
including proinflammatory cytokines, reactive oxygen intermediates, proteinases, and 
complement proteins (Giulian et al. 1995; McGeer et al. 1993; Rieske et al. 1989). 
Microglia derived oxygen free radicals as well as subsequent reaction products, hydrogen 
peroxide and peroxynitrite, have the potential to harm cells and have been implicated in 
contributing to oxidative damage and neurodegeneration in neurological diseases. Our 
findings show the inflammatory response in the brain long after initial impact and with 
the absence of detectable cell loss. It has been suggested that microglial activation in TBI 
cannot be exclusively attributable to the infiltration of blood-borne macrophages or 
molecules from the circulating blood. This implies that the microglial activation 
occurring is caused largely by intrinsic mechanisms within brain tissue, e.g .as a response 
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to diffuse axonal injury. Several recent reviews have suggested that inflammation may 
serve as a biomarker for bTBI (Agoston et al. 2009; Svetlov et al. 2009). Following a 
single severe blast, Kaur and colleagues previously demonstrated that there is widespread 
microglial activation up to 14 days post blast (Kaur et al. 1995). In addition, 
ultrastructural findings by Cernak and colleagues demonstrated glial reaction in the 
hippocampus of rats exposed to high levels of BOP (Cernak et al. 2001b). Recently Long 
and colleagues reported that following moderate levels of BOP (126 kPa) there was 
widespread gliosis throughout all levels of the brain (Long et al. 2009). However it was 
unclear whether microglia and/or astrocytes were activated and the regional pattern of 
inflammation remained uncertain.  
 It was recently shown that increased PK11195 binding in some brain areas 
corresponds with microglial activation following TBI (Benavides et al. 2001; 
Raghavendra Rao et al. 2000). In order to provide higher anatomical resolution of 
regional microglial activation following a moderate level of BOP we selected PK11195 
binding as a surrogate marker of microglial activation. We demonstrated increased 
PK11195 binding in the dentate gyrus, substantia nigra, and ventral hippocampus 5 days 
and 10 days after exposure to blast. At 10 days the inflammatory response appeared to be 
evolving further as increased binding was observed compared to 5 days. While at 5 days 
after exposure the distribution of lesions was localized bilaterally in both hemispheres, 
latter at 10 days increased binding density increase was distributed more contralaterally 
to the site of impact.  This distribution of microglia has some analogy with previously 
published data on the vasospasm distribution after exposure to blast. Unlike conventional 
TBI, traumatic cerebral vasospasm (TCV) often occurred in vessels far distal to the area 
93 
 
of fragment penetration in the hemisphere contralateral to the injury. It was suggested 
that, in addition to the fragment injury, propagation of the blast wave through the tissue 
could have caused TCV (Armonda et al. 2006). Another possibility is migration of toxic 
components of microglia activation products from the site of injury into distant regions 
(Gong et al. 2000).   
 The results presented clearly illustrate the selective vulnerability of the 
hippocampus and substantia nigra to BOP exposure. The high density of NMDA 
receptors present in the hippocampus may be partially responsible for the vulnerability of 
the hippocampus to excitotoxic insults (Butler et al. 2009). It was shown by positron 
electron tomography (PET) that PK11195 can visualize excitotoxic lesions in the living 
human brain (Groom et al. 1995). High vulnerability to oxidative stress of dopaminergic 
neurons in the substantia nigra and resultant mitochondrial dysfunction may contribute to 
the observed increase in microglia activation in substantia nigra (Hastings 2009). 
 Cernak and colleagues demonstrated that high levels of BOP result in an increase 
in brain nitric oxide production and lipid peroxidation as early as 3 h post-exposure that 
resolves by 5 days post-exposure. However, prior to the current study, oxidative stress 
following a moderate level of blast remained undetermined. Here we report that as early 
as 3 h post-exposure there is a significant increase in 3-NT and 4-HNE levels. At 24 h, 4-
HNE and 3-NT levels had returned to control values. This indicates that there is a rapid 
increase in oxidative stress following moderate BOP exposure and that oxidative stress is 
at least partially occurring concomitantly with BBB breakdown. It has been postulated 
that vascular abnormalities following TBI are dependent on the production of oxygen 
radicals (Kontos and Povlishock 1986; Pun et al. 2009). Therefore antioxidants may 
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represent one potential neuroprotective target for therapeutic intervention following 
bTBI, which may in turn reduce other downstream pathological processes (i.e. BBB 
breakdown). 
 In summary, our data demonstrate that bTBI likely share some common 
mechanisms of injury with other TBI models. In this study we demonstrated that 
inflammation likely plays a role in the neuropathology associated with bTBI. We report 
significant BBB breakdown that resolved by 3 days post exposure. Oxidative damage 
markers increased rapidly and resolved by 24 h post exposure. Taken together our results 
clearly show that the brain is susceptible to BOP exposure and that specific brain regions 
are more susceptible to blast than others. 
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5. CHAPTER 5 
Discussion and Conclusions 
5.1 Review 
 The wars in Iraq and Afghanistan have resulted in a high prevalence of TBI in 
military populations. Estimates of incidence of blast TBI range from 15-60 % of all 
deployed US military combatants (Ling et al. 2009). Since traumatic brain injury is often 
an “invisible wound”, its diagnosis can be extremely difficult, especially in the context of 
explosive blast injury. Currently, there is a great deal of investigation involving the 
mechanism(s) by which blast causes brain injury. In addition to the military contribution, 
mild TBI (concussion) in the US is gaining popular attention in the context of athletic 
injuries. In fact, over 18 % of all TBIs in the US are attributable to athletic injuries 
(Meehan and Bachur 2009). While concussion results in symptoms that usually resolve 
over the first few weeks following injury, some symptoms may persist for months to 
years.   
 The pathology associated with TBI occurs biphasically, with initial (primary) 
mechanical damage followed by a delayed secondary injury cascade. The secondary 
injury process is complex and involves multiple pathological events such as 
excitotoxicity, oxidative damage, mitochondrial dysfunction, and inflammation. 
Although the pathological processes following TBI are well defined an effective 
therapeutic for TBI remains elusive.    
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 The results from the experiments in this dissertation have demonstrated that: (I) 
Cyclophlin D plays a key role in TBI pathology and is a valid target for neuroprotective 
intervention; (II) Administration of NIM811, a CypD inhibitor, is neuroprotective and 
improves cognition following TBI; and (III) Blast exposure results in neuropathology 
similar to other models of TBI.   
5.2 Cyclophilin D’s involvement in TBI  
 Until now, CypD’s involvement in TBI pathology was entirely based on indirect 
evidence. This evidence was based on the assumption that the neuroprotective 
mechanism of CsA was through inhibition of CypD. Here we have demonstrated that 
genetic knockout of CypD increases tissue sparing and protects CA3 hippocampal 
neurons following TBI. These data suggest that CypD is a valid therapeutic target for 
TBI. 
 The selective protection of CA3 neurons observed in CypD knockout mice may 
be explained by the relative vulnerability of individual hippocampal subfields following 
insult. Selective vulnerability of CA1 neurons is well-documented following hypoxia-
ischemia insult (Kirino 1982; Kirino and Sano 1984). In fact, it has been shown that 
inhibition of complex II with malonate results in a selective loss of CA1 neurons in rats 
(Davolio and Greenamyre 1995). This may be especially relevant to these studies given 
that we observed only partial mitochondrial protection and that complex II driven 
respiration was significantly decreased in both wild-type and CypD knockout mice 
following TBI. Therefore, CA3 neurons maybe intrinsically less susceptible to insult and 
in turn maybe more amenable to therapy.   
97 
 
 Protection of CA3 neurons may have important implications for behavioral 
function following TBI. The CA3 region has been shown to play a critical role in spatial 
memory acquisition and in the formation of long-term spatial memory (Florian and 
Roullet 2004). Since CypD knockout resulted in CA3 protection this suggests that 
modulation of CypD may improve memory following TBI.        
 Next we choose to evaluate the efficacy of the CypD inhibitor, NIM811, 
following TBI. NIM811 is a more specific mPTP inhibitor than CsA and therefore has 
greater therapeutic potential. NIM811 resulted in significant neuroprotection which 
translated into improved behavioral function. Although we did not directly assess the 
effects of NIM811 treatment on hippocampal integrity, we speculate that the 
improvement in memory acquisition in NIM811 treated animals is related to a selective 
protection of CA3 neurons like we observed in our CypD knockout studies. Future 
studies may address the effects of NIM811 treatment on hippocampal integrity following 
TBI.  
 We also report that the protection produced by both genetic ablation of CypD and 
pharmacological inhibition of CypD with NIM811 is likely mediated through 
maintenance of mitochondrial function. An important phenomena associated with 
glutamate excitotoxicity is delayed calcium dysregulation (DCD) which refers to the 
delayed loss of Ca2+ homeostasis that leads to cell death (Starkov et al. 2004). Following 
glutamate exposure, initially intracellular Ca2+ levels of cultured neurons rapidly increase 
and fall (as a result of mitochondrial buffering of Ca2+), this is followed by a delayed 
irreversible increase in intracellular Ca2+ (Manev et al. 1989). This secondary rise in Ca2+ 
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is thought to be mediated by an increase in mitochondrial ROS production (Castilho et al. 
1999). Induction of mPTP, through an unknown mechanism, has been shown to result in 
increased ROS production (Kowaltowski et al. 1998). This increase in ROS production is 
thought to promote an increase in plasma membrane Ca2+ permeability (Wehage et al. 
2002). Inhibition of mPTP, through CypD knockout or pharmacological inhibition, is 
hypothesized to be the underlying mechanism of protection in the studies highlighted in 
this dissertation. In fact, the NIM811 studies demonstrated that inhibition of CypD results 
in decreased mitochondrial oxidative damage. Maintenance of mitochondrial homeostasis 
through modulation of CypD likely decreased ROS production and prevented DCD and 
subsequent cell death in these studies.  
 It is interesting that the observed dose-response curve for NIM811 and CsA are 
both U-shaped and that the optimal dose of NIM811 (10 mg/kg) is less than the optimal 
dose of CsA (20 mg/kg) (Sullivan et al. 2000b). Since the optimal dose of NIM811 is less 
than CsA this may indicate that it is a more potent inhibitor of mPTP than CsA in vivo.  
 Although these studies provide evidence that CypD plays a role in TBI the 
question related to the neuroprotective mechanism of CsA remains unanswered. In fact, 
these studies in which wild-type mice and CypD knockout mice are being administered 
CsA are ongoing in our laboratory. If knockout of CypD and administration of CsA 
results in an additive affect it would indicate that CsA is providing protection at least 
partially in a mechanism independent of CypD.  
  To date, CypD knockout has proven beneficial in multiple neurodegenerative 
models including hypoxic-ischemic brain injury and Alzheimer’s disease (Du et al. 2008; 
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Wang et al. 2009). Also, NIM811 has been shown to be neuroprotective in multiple CNS 
injury models including TBI, spinal cord injury, and transient focal forebrain ischemia 
(Korde et al. 2007; Mbye et al. 2008; McEwen et al. 2007). These studies, along with 
those contained in this dissertation, demonstrate that CypD is critically involved in TBI 
and that modulation of CypD following TBI has great therapeutic potential.  
5.3 Blast TBI 
 Because of improvements in body armor soldiers are surviving greater explosions 
and as such TBI has become a military epidemic. Also, the use of improvised explosive 
devices (IEDs) in Iraq and Afghanistan has contributed to the increased prevalence of 
TBI in the military. A renaissance in blast TBI research has occurred since the start of the 
current conflicts and it is increasingly evident that the brain is susceptible to primary blast 
forces. The development of relevant models of blast injury has shed new light on the 
pathology of blast TBI.  
 The studies presented here have attempted to characterize the time-course for 
well-established markers of TBI pathology in a clinically relevant blast TBI model. We 
showed that blast overpressure results in an early transient impairment of neurological 
function. The modest impairment likely indicates that our blast model is modeling a 
concussion-like injury. In fact, soldiers exposed to blast often report symptoms (i.e. 
confusion, amnesia, headache) consistent with concussion injury (Lippa et al. 2010). The 
similarity between the neurological impairment in our model and the clinical 
manifestation of blast are striking. In fact, studies by Long and colleagues have 
demonstrated that our blast model results in cognitive dysfunction as determined by 
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MWM performance (Long et al. 2009). These observations help validate the clinical 
relevancy of our model.  
 Our results demonstrate that brain oxidative damage occurs rapidly (<3 h) 
following TBI and resolves by 24 h post-injury. This increase in oxidative stress partially 
occurred concomitantly with increases in BBB permeability. Oxidative stress is known to 
promote BBB breakdown, which suggests a causal role for ROS in BBB dysfunction 
(Pun et al. 2009). Thus, antioxidant therapy may be one potential therapeutic strategy for 
blast TBI that could attenuate rises in ROS and in turn decrease alterations in BBB 
permeability.  
 Increased PK11195 binding has been shown to correlate with activated microglia 
following TBI (Woodcock 2009). As such we used PK11195 as a marker for activated 
microglia and showed that there is increased neuroinflammation in both the hippocampus 
and substantia nigra following blast. Since the hippocampus is intimately involved in 
memory, damage to the hippocampus could explain cognitive dysfunction following 
blast.  
5.3.1 Blast commentary 
 In studies which only subjected the head to blast (i.e. abdomen and chest shielded 
with a Kevlar vest) neuropathology was reduced compared to whole body blast 
(Koliatsos et al. 2011; Long et al. 2009). These data indicate a systemic involvement in 
brain injury following blast. One hypothesis is that forces from blast waves impacting the 
thorax are transmitted via the large blood vessels to the brain, resulting in damage 
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(Cernak and Noble-Haeusslein 2010). Also systemic injury could result in a production 
of proinflammatory cytokines which could enter the brain following BBB breakdown and 
promote inflammation. This may be true in our blast model since it has been shown to 
result in moderate pulmonary damage (Chavko et al. 2006). Therefore in our studies we 
cannot rule out a systemic (polytrauma) contribution to the observed brain injury in our 
blast model. 
 Clinical and experimental data suggests that repetitive mild TBI may cause 
cumulative damage to the brain (Weber 2007). Animal models have shown learning and 
cognitive dysfunction following repeated mild TBI that was absent following a single 
injury (DeFord et al. 2002) (Creeley et al. 2004). However the time lapse between the 
first injury and second injury appears to be an important determinant of overall outcome, 
if given enough time the brain may recover and the cumulative effect of the injuries may 
diminish (Weber 2007). Occupationally military personnel have an increased risk of 
repetitive BOP exposure and therefore may have a higher incidence of repetitive injury 
(Elsayed and Gorbunov 2007). The hypothesis that damage caused by one mild BOP 
exposure would have cumulative effects on the brain if BOP exposure is repeated needs 
attention. One group found that following three repeated low level blasts there was a 
dose-dependent increase in intracranial pressure (Saljo et al. 2009a). However, this study 
did not include any histopathological evidence of a cumulative effect of blast. These 
repeated blast studies would have important implications for return to work/combat 
guidelines for soldiers.   
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 The rationale behind pretreatment seems especially pertinent to military 
populations. Since the mechanisms of injury following TBI evolve rapidly, having a 
compound “on-board” at the time of injury may produce the greatest protection. Creatine 
is a commonly used dietary supplement that has neuroprotective efficacy and could be 
taken prophylactically by warfighters (Dedeoglu et al. 2003; Rabchevsky et al. 2003; 
Scheff and Dhillon 2004; Sullivan et al. 2000a). Creatine likely provides protection by 
maintaining mitochondrial homeostasis through increasing levels of phosphocreatine and 
maintaining mitochondrial structural integrity. Antioxidants, such as reveratrol, could be 
administered prophylactically to those at greater risk of TBI. Reserveratrol has been 
shown to be neuroprotective and improve cognition following TBI (Singleton et al. 
2010).   
 In summary, blast TBI represents a major public health problem with social and 
economic implications. Research initiatives elucidating the mechanisms of injury 
following blast will lead to the development of therapeutic strategies and better 
diagnostic tools.  
5.4 Concluding Remarks 
 Based on the results highlighted in this dissertation, along with reports from 
others, CypD plays a critical role in cell death following TBI and indicates that 
pharmacological inhibition of CypD remains a plausible therapeutic strategy for TBI. We 
chose to use NIM811 in our studies based on its specificity for CypD in relation to CsA. 
Indeed NIM811 administration conferred neuroprotection following TBI. These results 
warrant further studies evaluating the therapeutic window for NIM811.  Also, NIM811 
103 
 
efficacy needs to be determined in other models of TBI. Since our results indicate that 
blast causes neuropathology in the rat brain, further investigation is needed to evaluate 
neuroprotective compounds in blast TBI.  
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APPENDIX A: list of acronyms and abbreviations 
3-NT  - 3-nitrotyrosine 
4-HNE  - 4-hydroxynonenal 
AIF  - Apoptosis inducing factor 
AMPA  - α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptors 
ANT  - Adenine nucleotide translocase 
BBB  - Blood brain barrier 
BOP  - Blast overpressure 
bTBI  - Blast traumatic brain injury 
CCI  - Controlled cortical impact 
CsA  - Cyclosporin A 
cTBI  - Civilian traumatic brain injury 
CypD  - Cyclophilin D 
DCD  - Delayed calcium dysregulation 
ETC  - Electron transport chain 
GCS  - Glasgow Coma Scale 
mPTP  - Mitochondrial Permeability transition pore 
MWM  - Morris Water Maze 
NIM811 - N-methyl-4-isoleucine-cyclosporin 
NMDA  - N-methyl-daspartate 
PBR  - Peripheral benzodiazepine receptor 
ROS  - Reactive oxygen species 
TBI  - Traumatic brain injury 
TPSO  - Translocator protein  
VDAC  - Voltage-dependent anion channel 
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APPENDIX B: Effects of CypD on spatial memory 
 
Morris Water Maze training data collapsed across all training days. CypD knockout 
resulted in a genotype-specific decrease in MWM performance compared to wild-type. 
Similar results were reported by Mouri and colleagues (Mouri et al. 2010). In these 
studies, inhibition of CypD with CsA produced similar MWM deficits as CypD 
knockout.      
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APPENDIX C: Ca2+ buffering capacity of CypD knockout mitochondria and wild-type 
mitochondria 
 
Mitochondria isolated from naïve wild-type and CypD knockout animals were used to 
assess the effect of in vitro NIM811 treatment (1 µM) on mitochondrial Ca2+ buffering 
capacity and mPTP. CypD knockout mitochondria were capable of buffering 
approximately 20 % more Ca2+ before undergoing mPTP than wild-type mitochondria. 
CypD knockout and wild-type + NIM811 mitochondria demonstrated similar Ca2+ 
buffering capacity.   
 
 
 
 
 
 
 
107 
 
REFERENCES 
 
Agoston DV, Gyorgy A, Eidelman O, Pollard HB. 2009. Proteomic biomarkers for blast 
neurotrauma: targeting cerebral edema, inflammation, and neuronal death 
cascades. J Neurotrauma 26(6):901-911. 
Albensi BC, Sullivan PG, Thompson MB, Scheff SW, Mattson MP. 2000. Cyclosporin 
ameliorates traumatic brain-injury-induced alterations of hippocampal synaptic 
plasticity. Exp Neurol 162(2):385-389. 
Alberts B. 2002. Molecular biology of the cell. New York: Garland Science. xxxiv, 
[1548] p. p. 
Alessandri B, Rice AC, Levasseur J, DeFord M, Hamm RJ, Bullock MR. 2002. 
Cyclosporin A improves brain tissue oxygen consumption and learning/memory 
performance after lateral fluid percussion injury in rats. J Neurotrauma 19(7):829-
841. 
Amor S, Puentes F, Baker D, van der Valk P. 2010. Inflammation in neurodegenerative 
diseases. Immunology 129(2):154-169. 
Andreeva L, Heads R, Green CJ. 1999. Cyclophilins and their possible role in the stress 
response. Int J Exp Pathol 80(6):305-315. 
Andriessen TM, Jacobs B, Vos PE. 2010. Clinical characteristics and pathophysiological 
mechanisms of focal and diffuse traumatic brain injury. J Cell Mol Med 
14(10):2381-2392. 
Armonda RA, Bell RS, Vo AH, Ling G, DeGraba TJ, Crandall B, Ecklund J, Campbell 
WW. 2006. Wartime traumatic cerebral vasospasm: recent review of combat 
casualties. Neurosurgery 59(6):1215-1225; discussion 1225. 
Axelsson H, Hjelmqvist H, Medin A, Persson JK, Suneson A. 2000. Physiological 
changes in pigs exposed to a blast wave from a detonating high-explosive charge. 
Military medicine 165(2):119-126. 
Azbill RD, Mu X, Bruce-Keller AJ, Mattson MP, Springer JE. 1997. Impaired 
mitochondrial function, oxidative stress and altered antioxidant enzyme activities 
following traumatic spinal cord injury. Brain Res 765(2):283-290. 
Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, 
Sayen MR, Gottlieb RA, Dorn GW, Robbins J, Molkentin JD. 2005. Loss of 
cyclophilin D reveals a critical role for mitochondrial permeability transition in 
cell death. Nature 434(7033):658-662. 
Baldwin SA, Gibson T, Callihan CT, Sullivan PG, Palmer E, Scheff SW. 1997. Neuronal 
cell loss in the CA3 subfield of the hippocampus following cortical contusion 
utilizing the optical disector method for cell counting. J Neurotrauma 14(6):385-
398. 
Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, Bernardi P. 2005. Properties of the 
permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol 
Chem 280(19):18558-18561. 
Bauman RA, Elsayed N, Petras JM, Widholm J. 1997. Exposure to sublethal blast 
overpressure reduces the food intake and exercise performance of rats. 
Toxicology 121(1):65-79. 
108 
 
Beaumont A, Marmarou A, Czigner A, Yamamoto M, Demetriadou K, Shirotani T, 
Marmarou C, Dunbar J. 1999. The impact-acceleration model of head injury: 
injury severity predicts motor and cognitive performance after trauma. Neurol Res 
21(8):742-754. 
Beaumont A, Marmarou A, Hayasaki K, Barzo P, Fatouros P, Corwin F, Marmarou C, 
Dunbar J. 2000. The permissive nature of blood brain barrier (BBB) opening in 
edema formation following traumatic brain injury. Acta Neurochir Suppl 76:125-
129. 
Benavides J, Dubois A, Scatton B. 2001. Peripheral type benzodiazepine binding sites as 
a tool for the detection and quantification of CNS injury. Curr Protoc Neurosci 
Chapter 7:Unit7 16. 
Bisler S, Schleicher A, Gass P, Stehle JH, Zilles K, Staiger JF. 2002. Expression of c-
Fos, ICER, Krox-24 and JunB in the whisker-to-barrel pathway of rats: time 
course of induction upon whisker stimulation by tactile exploration of an enriched 
environment. J Chem Neuroanat 23(3):187-198. 
Braughler JM, Hall ED. 1992. Involvement of lipid peroxidation in CNS injury. J 
Neurotrauma 9 Suppl 1:S1-7. 
Brown MR, Sullivan PG, Geddes JW. 2006. Synaptic mitochondria are more susceptible 
to Ca2+overload than nonsynaptic mitochondria. J Biol Chem 281(17):11658-
11668. 
Bruns JJ, Jr., Jagoda AS. 2009. Mild traumatic brain injury. Mt Sinai J Med 76(2):129-
137. 
Bryant RA. 2001. Posttraumatic stress disorder and traumatic brain injury: can they co-
exist? Clin Psychol Rev 21(6):931-948. 
Buki A, Okonkwo DO, Povlishock JT. 1999. Postinjury cyclosporin A administration 
limits axonal damage and disconnection in traumatic brain injury. J Neurotrauma 
16(6):511-521. 
Butler TR, Self RL, Smith KJ, Sharrett-Field LJ, Berry JN, Littleton JM, Pauly JR, 
Mulholland PJ, Prendergast MA. 2009. Selective vulnerability of hippocampal 
cornu ammonis 1 pyramidal cells to excitotoxic insult is associated with the 
expression of polyamine-sensitive N-methyl-D-asparate-type glutamate receptors. 
Neuroscience 165(2):525-534. 
Castilho RF, Ward MW, Nicholls DG. 1999. Oxidative stress, mitochondrial function, 
and acute glutamate excitotoxicity in cultured cerebellar granule cells. J 
Neurochem 72(4):1394-1401. 
Cernak I, Noble-Haeusslein LJ. 2010. Traumatic brain injury: an overview of 
pathobiology with emphasis on military populations. J Cereb Blood Flow Metab 
30(2):255-266. 
Cernak I, Savic J, Ignjatovic D, Jevtic M. 1999. Blast injury from explosive munitions. J 
Trauma 47(1):96-103; discussion 103-104. 
Cernak I, Wang Z, Jiang J, Bian X, Savic J. 2001a. Cognitive deficits following blast 
injury-induced neurotrauma: possible involvement of nitric oxide. Brain Inj 
15(7):593-612. 
Cernak I, Wang Z, Jiang J, Bian X, Savic J. 2001b. Ultrastructural and functional 
characteristics of blast injury-induced neurotrauma. J Trauma 50(4):695-706. 
109 
 
Chavko M, Prusaczyk WK, McCarron RM. 2006. Lung injury and recovery after 
exposure to blast overpressure. The Journal of trauma 61(4):933-942. 
Chen MK, Guilarte TR. 2008. Translocator protein 18 kDa (TSPO): molecular sensor of 
brain injury and repair. Pharmacol Ther 118(1):1-17. 
Cook AM, Whitlow J, Hatton J, Young B. 2009. Cyclosporine A for neuroprotection: 
establishing dosing guidelines for safe and effective use. Expert Opin Drug Saf 
8(4):411-419. 
Corrigan JD, Selassie AW, Orman JA. 2010. The epidemiology of traumatic brain injury. 
J Head Trauma Rehabil 25(2):72-80. 
Creeley CE, Wozniak DF, Bayly PV, Olney JW, Lewis LM. 2004. Multiple episodes of 
mild traumatic brain injury result in impaired cognitive performance in mice. 
Acad Emerg Med 11(8):809-819. 
Crompton M. 1999. The mitochondrial permeability transition pore and its role in cell 
death. Biochem J 341 ( Pt 2):233-249. 
Crompton M, Costi A. 1990. A heart mitochondrial Ca2(+)-dependent pore of possible 
relevance to re-perfusion-induced injury. Evidence that ADP facilitates pore 
interconversion between the closed and open states. Biochem J 266(1):33-39. 
Crompton M, Ellinger H, Costi A. 1988. Inhibition by cyclosporin A of a Ca2+-
dependent pore in heart mitochondria activated by inorganic phosphate and 
oxidative stress. Biochem J 255(1):357-360. 
Davis LM, Pauly JR, Readnower RD, Rho JM, Sullivan PG. 2008. Fasting is 
neuroprotective following traumatic brain injury. J Neurosci Res 86(8):1812-
1822. 
Davolio C, Greenamyre JT. 1995. Selective vulnerability of the CA1 region of 
hippocampus to the indirect excitotoxic effects of malonic acid. Neurosci Lett 
192(1):29-32. 
Dedeoglu A, Kubilus JK, Yang L, Ferrante KL, Hersch SM, Beal MF, Ferrante RJ. 2003. 
Creatine therapy provides neuroprotection after onset of clinical symptoms in 
Huntington's disease transgenic mice. J Neurochem 85(6):1359-1367. 
DeFord SM, Wilson MS, Rice AC, Clausen T, Rice LK, Barabnova A, Bullock R, Hamm 
RJ. 2002. Repeated mild brain injuries result in cognitive impairment in B6C3F1 
mice. Journal of neurotrauma 19(4):427-438. 
Deng-Bryant Y, Singh IN, Carrico KM, Hall ED. 2008. Neuroprotective effects of 
tempol, a catalytic scavenger of peroxynitrite-derived free radicals, in a mouse 
traumatic brain injury model. J Cereb Blood Flow Metab 28(6):1114-1126. 
Deng Y, Thompson BM, Gao X, Hall ED. 2007. Temporal relationship of peroxynitrite-
induced oxidative damage, calpain-mediated cytoskeletal degradation and 
neurodegeneration after traumatic brain injury. Exp Neurol 205(1):154-165. 
Denny-Brown D, Russell WR. 1940. Experimental cerebral concussion. J Physiol 
99(1):153. 
DePalma RG, Burris DG, Champion HR, Hodgson MJ. 2005. Blast injuries. The New 
England journal of medicine 352(13):1335-1342. 
Dewitt DS, Prough DS. 2008. Blast-Induced Brain Injury and Posttraumatic Hypotension 
and Hypoxemia. Journal of neurotrauma. 
110 
 
Dixon CE, Lyeth BG, Povlishock JT, Findling RL, Hamm RJ, Marmarou A, Young HF, 
Hayes RL. 1987. A fluid percussion model of experimental brain injury in the rat. 
J Neurosurg 67(1):110-119. 
Donkin JJ, Vink R. 2010. Mechanisms of cerebral edema in traumatic brain injury: 
therapeutic developments. Curr Opin Neurol 23(3):293-299. 
Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, 
Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD. 
2008. Cyclophilin D deficiency attenuates mitochondrial and neuronal 
perturbation and ameliorates learning and memory in Alzheimer's disease. Nat 
Med 14(10):1097-1105. 
Du H, Guo L, Zhang W, Rydzewska M, Yan S. 2011. Cyclophilin D deficiency improves 
mitochondrial function and learning/memory in aging Alzheimer disease mouse 
model. Neurobiol Aging 32(3):398-406. 
Dubois A, Benavides J, Peny B, Duverger D, Fage D, Gotti B, MacKenzie ET, Scatton B. 
1988. Imaging of primary and remote ischaemic and excitotoxic brain lesions. An 
autoradiographic study of peripheral type benzodiazepine binding sites in the rat 
and cat. Brain Res 445(1):77-90. 
Elder GA, Cristian A. 2009. Blast-related mild traumatic brain injury: mechanisms of 
injury and impact on clinical care. Mt Sinai J Med 76(2):111-118. 
Elsayed NM. 1997. Toxicology of blast overpressure. Toxicology 121(1):1-15. 
Elsayed NM, Gorbunov NV. 2007. Pulmonary biochemical and histological alterations 
after repeated low-level blast overpressure exposures. Toxicol Sci 95(1):289-296. 
Enters EK, Pascua JR, McDowell KP, Kapasi MZ, Povlishock JT, Robinson SE. 1992. 
Blockade of acute hypertensive response does not prevent changes in behavior or 
in CSF acetylcholine (ACH) content following traumatic brain injury (TBI). Brain 
Res 576(2):271-276. 
Faden AI, Demediuk P, Panter SS, Vink R. 1989. The role of excitatory amino acids and 
NMDA receptors in traumatic brain injury. Science 244(4906):798-800. 
Fijalkowski RJ, Stemper BD, Pintar FA, Yoganandan N, Crowe MJ, Gennarelli TA. 
2007. New rat model for diffuse brain injury using coronal plane angular 
acceleration. J Neurotrauma 24(8):1387-1398. 
Finkel MF. 2006. The neurological consequences of explosives. Journal of the 
neurological sciences 249(1):63-67. 
Florian C, Roullet P. 2004. Hippocampal CA3-region is crucial for acquisition and 
memory consolidation in Morris water maze task in mice. Behav Brain Res 
154(2):365-374. 
Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T. 1998. Cyclosporin 
A, but not FK 506, protects mitochondria and neurons against hypoglycemic 
damage and implicates the mitochondrial permeability transition in cell death. J 
Neurosci 18(14):5151-5159. 
Gaetz M. 2004. The neurophysiology of brain injury. Clin Neurophysiol 115(1):4-18. 
Giacomello M, Drago I, Pizzo P, Pozzan T. 2007. Mitochondrial Ca2+ as a key regulator 
of cell life and death. Cell Death Differ 14(7):1267-1274. 
Gilmer LK, Roberts KN, Joy K, Sullivan PG, Scheff SW. 2009. Early mitochondrial 
dysfunction after cortical contusion injury. J Neurotrauma 26(8):1271-1280. 
111 
 
Giulian D, Li J, Bartel S, Broker J, Li X, Kirkpatrick JB. 1995. Cell surface morphology 
identifies microglia as a distinct class of mononuclear phagocyte. J Neurosci 
15(11):7712-7726. 
Gong C, Hoff JT, Keep RF. 2000. Acute inflammatory reaction following experimental 
intracerebral hemorrhage in rat. Brain Res 871(1):57-65. 
Gorbunov NV, McFaul SJ, Van Albert S, Morrissette C, Zaucha GM, Nath J. 2004. 
Assessment of inflammatory response and sequestration of blood iron transferrin 
complexes in a rat model of lung injury resulting from exposure to low-frequency 
shock waves. Crit Care Med 32(4):1028-1034. 
Gotti B, Benavides J, MacKenzie ET, Scatton B. 1990. The pharmacotherapy of focal 
cortical ischaemia in the mouse. Brain Res 522(2):290-307. 
Green DR, Kroemer G. 2004. The pathophysiology of mitochondrial cell death. Science 
305(5684):626-629. 
Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science 281(5381):1309-1312. 
Griffiths EJ, Halestrap AP. 1991. Further evidence that cyclosporin A protects 
mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-
trans isomerase. Implications for the immunosuppressive and toxic effects of 
cyclosporin. Biochem J 274 ( Pt 2):611-614. 
Groom GN, Junck L, Foster NL, Frey KA, Kuhl DE. 1995. PET of peripheral 
benzodiazepine binding sites in the microgliosis of Alzheimer's disease. J Nucl 
Med 36(12):2207-2210. 
Grossman R, Shohami E, Alexandrovich A, Yatsiv I, Kloog Y, Biegon A. 2003. Increase 
in peripheral benzodiazepine receptors and loss of glutamate NMDA receptors in 
a mouse model of closed head injury: a quantitative autoradiographic study. 
Neuroimage 20(4):1971-1981. 
Gunter KK, Gunter TE. 1994. Transport of calcium by mitochondria. J Bioenerg 
Biomembr 26(5):471-485. 
Gunter TE, Gunter KK. 2001. Uptake of calcium by mitochondria: transport and possible 
function. IUBMB Life 52(3-5):197-204. 
Guseva MV, Hopkins DM, Scheff SW, Pauly JR. 2008. Dietary choline supplementation 
improves behavioral, histological, and neurochemical outcomes in a rat model of 
traumatic brain injury. J Neurotrauma 25(8):975-983. 
Hailer NP. 2008. Immunosuppression after traumatic or ischemic CNS damage: it is 
neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 
84(3):211-233. 
Halestrap AP. 2009. What is the mitochondrial permeability transition pore? J Mol Cell 
Cardiol 46(6):821-831. 
Halestrap AP, Brenner C. 2003. The adenine nucleotide translocase: a central component 
of the mitochondrial permeability transition pore and key player in cell death. 
Curr Med Chem 10(16):1507-1525. 
Halestrap AP, Woodfield KY, Connern CP. 1997. Oxidative stress, thiol reagents, and 
membrane potential modulate the mitochondrial permeability transition by 
affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 
272(6):3346-3354. 
112 
 
Hall ED, Braughler JM. 1993. Free radicals in CNS injury. Res Publ Assoc Res Nerv 
Ment Dis 71:81-105. 
Hall ED, Braughler JM, McCall JM. 1992. Antioxidant effects in brain and spinal cord 
injury. J Neurotrauma 9 Suppl 1:S165-172. 
Hall ED, Detloff MR, Johnson K, Kupina NC. 2004. Peroxynitrite-mediated protein 
nitration and lipid peroxidation in a mouse model of traumatic brain injury. J 
Neurotrauma 21(1):9-20. 
Hall ED, Sullivan PG, Gibson TR, Pavel KM, Thompson BM, Scheff SW. 2005. Spatial 
and temporal characteristics of neurodegeneration after controlled cortical impact 
in mice: more than a focal brain injury. J Neurotrauma 22(2):252-265. 
Hall ED, Vaishnav RA, Mustafa AG. 2010. Antioxidant therapies for traumatic brain 
injury. Neurotherapeutics 7(1):51-61. 
Halliwell B, Gutteridge JMC. 2007. Free radicals in biology and medicine. Oxford ; New 
York: Oxford University Press. xxxvi, 851 p., [858] p. of plates p. 
Hamm RJ. 2001. Neurobehavioral assessment of outcome following traumatic brain 
injury in rats: an evaluation of selected measures. J Neurotrauma 18(11):1207-
1216. 
Hansson MJ, Mansson R, Morota S, Uchino H, Kallur T, Sumi T, Ishii N, Shimazu M, 
Keep MF, Jegorov A, Elmer E. 2008. Calcium-induced generation of reactive 
oxygen species in brain mitochondria is mediated by permeability transition. Free 
Radic Biol Med 45(3):284-294. 
Hastings TG. 2009. The role of dopamine oxidation in mitochondrial dysfunction: 
implications for Parkinson's disease. J Bioenerg Biomembr 41(6):469-472. 
Hatton J. 2001. Pharmacological treatment of traumatic brain injury: a review of agents 
in development. CNS Drugs 15(7):553-581. 
Haworth RA, Hunter DR. 1979. The Ca2+-induced membrane transition in mitochondria. 
II. Nature of the Ca2+ trigger site. Arch Biochem Biophys 195(2):460-467. 
Hickey WF, Hsu BL, Kimura H. 1991. T-lymphocyte entry into the central nervous 
system. J Neurosci Res 28(2):254-260. 
Hinzman JM, Thomas TC, Burmeister JJ, Quintero JE, Huettl P, Pomerleau F, Gerhardt 
GA, Lifshitz J. 2010. Diffuse brain injury elevates tonic glutamate levels and 
potassium-evoked glutamate release in discrete brain regions at two days post-
injury: an enzyme-based microelectrode array study. J Neurotrauma 27(5):889-
899. 
Hoane MR, Kaplan SA, Ellis AL. 2006. The effects of nicotinamide on apoptosis and 
blood-brain barrier breakdown following traumatic brain injury. Brain Res 
1125(1):185-193. 
Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. 2008. Mild traumatic 
brain injury in U.S. Soldiers returning from Iraq. The New England journal of 
medicine 358(5):453-463. 
Hunter DR, Haworth RA. 1979a. The Ca2+-induced membrane transition in 
mitochondria. I. The protective mechanisms. Arch Biochem Biophys 195(2):453-
459. 
113 
 
Hunter DR, Haworth RA. 1979b. The Ca2+-induced membrane transition in 
mitochondria. III. Transitional Ca2+ release. Arch Biochem Biophys 195(2):468-
477. 
Jones E, Fear NT, Wessely S. 2007. Shell shock and mild traumatic brain injury: a 
historical review. The American journal of psychiatry 164(11):1641-1645. 
Jordan J, Cena V, Prehn JH. 2003. Mitochondrial control of neuron death and its role in 
neurodegenerative disorders. J Physiol Biochem 59(2):129-141. 
Kaur C, Singh J, Lim MK, Ng BL, Yap EP, Ling EA. 1995. The response of neurons and 
microglia to blast injury in the rat brain. Neuropathol Appl Neurobiol 21(5):369-
377. 
Kelley BJ, Lifshitz J, Povlishock JT. 2007. Neuroinflammatory responses after 
experimental diffuse traumatic brain injury. J Neuropathol Exp Neurol 
66(11):989-1001. 
Kilbaugh TJ, Bhandare S, Lorom DH, Saraswati M, Robertson CL, Margulies SS. 2011. 
Cyclosporin A Preserves Mitochondrial Function after Traumatic Brain Injury in 
the Immature Rat and Piglet. J Neurotrauma. 
Kirino T. 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. 
Brain Res 239(1):57-69. 
Kirino T, Sano K. 1984. Selective vulnerability in the gerbil hippocampus following 
transient ischemia. Acta Neuropathol 62(3):201-208. 
Koliatsos VE, Cernak I, Xu L, Song Y, Savonenko A, Crain BJ, Eberhart CG, Frangakis 
CE, Melnikova T, Kim H, Lee D. 2011. A mouse model of blast injury to brain: 
initial pathological, neuropathological, and behavioral characterization. J 
Neuropathol Exp Neurol 70(5):399-416. 
Komary Z, Tretter L, Adam-Vizi V. 2010. Membrane potential-related effect of calcium 
on reactive oxygen species generation in isolated brain mitochondria. Biochim 
Biophys Acta 1797(6-7):922-928. 
Kontos HA, Povlishock JT. 1986. Oxygen radicals in brain injury. Cent Nerv Syst 
Trauma 3(4):257-263. 
Korde AS, Pettigrew LC, Craddock SD, Pocernich CB, Waldmeier PC, Maragos WF. 
2007. Protective effects of NIM811 in transient focal cerebral ischemia suggest 
involvement of the mitochondrial permeability transition. J Neurotrauma 
24(5):895-908. 
Kowaltowski AJ, Castilho RF, Vercesi AE. 1995. Ca(2+)-induced mitochondrial 
membrane permeabilization: role of coenzyme Q redox state. Am J Physiol 269(1 
Pt 1):C141-147. 
Kowaltowski AJ, Naia-da-Silva ES, Castilho RF, Vercesi AE. 1998. Ca2+-stimulated 
mitochondrial reactive oxygen species generation and permeability transition are 
inhibited by dibucaine or Mg2+. Arch Biochem Biophys 359(1):77-81. 
Langlois JA, Rutland-Brown W, Wald MM. 2006. The epidemiology and impact of 
traumatic brain injury: a brief overview. J Head Trauma Rehabil 21(5):375-378. 
LaPlaca MC, Simon CM, Prado GR, Cullen DK. 2007. CNS injury biomechanics and 
experimental models. Prog Brain Res 161:13-26. 
114 
 
Lemasters JJ, Theruvath TP, Zhong Z, Nieminen AL. 2009. Mitochondrial calcium and 
the permeability transition in cell death. Biochim Biophys Acta 1787(11):1395-
1401. 
Li V, Brustovetsky T, Brustovetsky N. 2009. Role of cyclophilin D-dependent 
mitochondrial permeability transition in glutamate-induced calcium deregulation 
and excitotoxic neuronal death. Exp Neurol 218(2):171-182. 
Lifshitz J, Friberg H, Neumar RW, Raghupathi R, Welsh FA, Janmey P, Saatman KE, 
Wieloch T, Grady MS, McIntosh TK. 2003. Structural and functional damage 
sustained by mitochondria after traumatic brain injury in the rat: evidence for 
differentially sensitive populations in the cortex and hippocampus. J Cereb Blood 
Flow Metab 23(2):219-231. 
Lifshitz J, Sullivan PG, Hovda DA, Wieloch T, McIntosh TK. 2004. Mitochondrial 
damage and dysfunction in traumatic brain injury. Mitochondrion 4(5-6):705-713. 
Lim R, Lajtha A. 2006. Handbook of neurochemistry and molecular neurobiology. 
Neuroactive proteins and peptides. New York, NY: Springer. xii, 681 p. p. 
Ling G, Bandak F, Armonda R, Grant G, Ecklund J. 2009. Explosive blast neurotrauma. J 
Neurotrauma 26(6):815-825. 
Lippa SM, Pastorek NJ, Benge JF, Thornton GM. 2010. Postconcussive symptoms after 
blast and nonblast-related mild traumatic brain injuries in Afghanistan and Iraq 
war veterans. J Int Neuropsychol Soc 16(5):856-866. 
Long JB, Bentley TL, Wessner KA, Cerone C, Sweeney S, Bauman RA. 2009. Blast 
overpressure in rats: recreating a battlefield injury in the laboratory. J 
Neurotrauma 26(6):827-840. 
Maciel EN, Vercesi AE, Castilho RF. 2001. Oxidative stress in Ca(2+)-induced 
membrane permeability transition in brain mitochondria. J Neurochem 
79(6):1237-1245. 
Manev H, Favaron M, Guidotti A, Costa E. 1989. Delayed increase of Ca2+ influx 
elicited by glutamate: role in neuronal death. Mol Pharmacol 36(1):106-112. 
Matsushita Y, Shima K, Nawashiro H, Wada K, Tsuzuki N, Miyazawa T. 2000. Real 
time monitoring of glutamate following fluid percussion brain injury with hypoxia 
in the rat. Acta Neurochir Suppl 76:207-212. 
Mayorga MA. 1997. The pathology of primary blast overpressure injury. Toxicology 
121(1):17-28. 
Mazzeo AT, Beat A, Singh A, Bullock MR. 2009. The role of mitochondrial transition 
pore, and its modulation, in traumatic brain injury and delayed neurodegeneration 
after TBI. Exp Neurol 218(2):363-370. 
Mbye LH, Singh IN, Carrico KM, Saatman KE, Hall ED. 2009. Comparative 
neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive 
cyclosporin A analog, following traumatic brain injury. J Cereb Blood Flow 
Metab 29(1):87-97. 
Mbye LH, Singh IN, Sullivan PG, Springer JE, Hall ED. 2008. Attenuation of acute 
mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a non-
immunosuppressive cyclosporin A analog. Exp Neurol 209(1):243-253. 
McCall JM, Braughler JM, Hall ED. 1987. Lipid peroxidation and the role of oxygen 
radicals in CNS injury. Acta Anaesthesiol Belg 38(4):373-379. 
115 
 
McEwen ML, Sullivan PG, Springer JE. 2007. Pretreatment with the cyclosporin 
derivative, NIM811, improves the function of synaptic mitochondria following 
spinal cord contusion in rats. J Neurotrauma 24(4):613-624. 
McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. 1993. 
Microglia in degenerative neurological disease. Glia 7(1):84-92. 
McGinn MJ, Kelley BJ, Akinyi L, Oli MW, Liu MC, Hayes RL, Wang KK, Povlishock 
JT. 2009. Biochemical, structural, and biomarker evidence for calpain-mediated 
cytoskeletal change after diffuse brain injury uncomplicated by contusion. J 
Neuropathol Exp Neurol 68(3):241-249. 
Meehan WP, 3rd, Bachur RG. 2009. Sport-related concussion. Pediatrics 123(1):114-123. 
Michel RP, Cruz-Orive LM. 1988. Application of the Cavalieri principle and vertical 
sections method to lung: estimation of volume and pleural surface area. J Microsc 
150(Pt 2):117-136. 
Moochhala SM, Md S, Lu J, Teng CH, Greengrass C. 2004. Neuroprotective role of 
aminoguanidine in behavioral changes after blast injury. J Trauma 56(2):393-403. 
Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. 2002. Inflammatory 
response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit 
Care 8(2):101-105. 
Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. 2007. Modulation of 
immune response by head injury. Injury 38(12):1392-1400. 
Morris R. 1984. Developments of a water-maze procedure for studying spatial learning in 
the rat. J Neurosci Methods 11(1):47-60. 
Mouri A, Noda Y, Shimizu S, Tsujimoto Y, Nabeshima T. 2010. The role of cyclophilin 
D in learning and memory. Hippocampus 20(2):293-304. 
Mundie TG, Dodd KT, Lagutchik MS, Morris JR, Martin D. 2000. Effects of blast 
exposure on exercise performance in sheep. J Trauma 48(6):1115-1121. 
Mustafa AG, Singh IN, Wang J, Carrico KM, Hall ED. 2010. Mitochondrial protection 
after traumatic brain injury by scavenging lipid peroxyl radicals. J Neurochem 
114(1):271-280. 
Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, 
Kubo T, Tsujimoto Y. 2005. Cyclophilin D-dependent mitochondrial permeability 
transition regulates some necrotic but not apoptotic cell death. Nature 
434(7033):652-658. 
Nicholls DG. 2002. Mitochondrial function and dysfunction in the cell: its relevance to 
aging and aging-related disease. Int J Biochem Cell Biol 34(11):1372-1381. 
Nicholls DG, Ferguson SJ. 2002. Bioenergetics 3. San Diego, Calif.: Academic Press. 
xviii, 297 p. p. 
Nicolli A, Basso E, Petronilli V, Wenger RM, Bernardi P. 1996. Interactions of 
cyclophilin with the mitochondrial inner membrane and regulation of the 
permeability transition pore, and cyclosporin A-sensitive channel. J Biol Chem 
271(4):2185-2192. 
Nolan S. 2005. Traumatic brain injury: a review. Crit Care Nurs Q 28(2):188-194. 
Okonkwo DO, Buki A, Siman R, Povlishock JT. 1999. Cyclosporin A limits calcium-
induced axonal damage following traumatic brain injury. Neuroreport 10(2):353-
358. 
116 
 
Okonkwo DO, Povlishock JT. 1999. An intrathecal bolus of cyclosporin A before injury 
preserves mitochondrial integrity and attenuates axonal disruption in traumatic 
brain injury. J Cereb Blood Flow Metab 19(4):443-451. 
Pandya JD, Pauly JR, Nukala VN, Sebastian AH, Day KM, Korde AS, Maragos WF, 
Hall ED, Sullivan PG. 2007. Post-Injury Administration of Mitochondrial 
Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome 
following Traumatic Brain Injury in Rodents. J Neurotrauma 24(5):798-811. 
Patel MN. 2002. Oxidative stress, mitochondrial dysfunction, and epilepsy. Free Radic 
Res 36(11):1139-1146. 
Patel SP, Sullivan PG, Lyttle TS, Rabchevsky AG. 2010. Acetyl-L-carnitine ameliorates 
mitochondrial dysfunction following contusion spinal cord injury. J Neurochem 
114(1):291-301. 
Pun PB, Lu J, Moochhala S. 2009. Involvement of ROS in BBB dysfunction. Free Radic 
Res 43(4):348-364. 
Rabchevsky AG, Sullivan PG, Fugaccia I, Scheff SW. 2003. Creatine diet supplement for 
spinal cord injury: influences on functional recovery and tissue sparing in rats. J 
Neurotrauma 20(7):659-669. 
Raghavendra Rao VL, Dogan A, Bowen KK, Dempsey RJ. 2000. Traumatic brain injury 
leads to increased expression of peripheral-type benzodiazepine receptors, 
neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp 
Neurol 161(1):102-114. 
Ravikumar R, McEwen ML, Springer JE. 2007. Post-treatment with the cyclosporin 
derivative, NIM811, reduced indices of cell death and increased the volume of 
spared tissue in the acute period following spinal cord contusion. J Neurotrauma 
24(10):1618-1630. 
Readnower RD, Chavko M, Adeeb S, Conroy MD, Pauly JR, McCarron RM, Sullivan 
PG. 2010. Increase in blood-brain barrier permeability, oxidative stress, and 
activated microglia in a rat model of blast-induced traumatic brain injury. J 
Neurosci Res 88(16):3530-3539. 
Redell JB, Zhao J, Dash PK. 2007. Acutely increased cyclophilin a expression after brain 
injury: a role in blood-brain barrier function and tissue preservation. J Neurosci 
Res 85(9):1980-1988. 
Reed TT, Owen J, Pierce WM, Sebastian A, Sullivan PG, Butterfield DA. 2009. 
Proteomic identification of nitrated brain proteins in traumatic brain-injured rats 
treated postinjury with gamma-glutamylcysteine ethyl ester: insights into the role 
of elevation of glutathione as a potential therapeutic strategy for traumatic brain 
injury. J Neurosci Res 87(2):408-417. 
Rho JM. 2004. Basic science behind the catastrophic epilepsies. Epilepsia 45 Suppl 5:5-
11. 
Rho JM, Sankar R, Stafstrom CE. 2010. Epilepsy : mechanisms, models, and 
translational perspectives. Boca Raton: Taylor & Francis. p. p. 
Rieske E, Graeber MB, Tetzlaff W, Czlonkowska A, Streit WJ, Kreutzberg GW. 1989. 
Microglia and microglia-derived brain macrophages in culture: generation from 
axotomized rat facial nuclei, identification and characterization in vitro. Brain Res 
492(1-2):1-14. 
117 
 
Riess P, Bareyre FM, Saatman KE, Cheney JA, Lifshitz J, Raghupathi R, Grady MS, 
Neugebauer E, McIntosh TK. 2001. Effects of chronic, post-injury Cyclosporin A 
administration on motor and sensorimotor function following severe, 
experimental traumatic brain injury. Restor Neurol Neurosci 18(1):1-8. 
Robertson CL. 2004. Mitochondrial dysfunction contributes to cell death following 
traumatic brain injury in adult and immature animals. J Bioenerg Biomembr 
36(4):363-368. 
Robertson CL, Saraswati M, Fiskum G. 2007. Mitochondrial dysfunction early after 
traumatic brain injury in immature rats. J Neurochem 101(5):1248-1257. 
Rosenwirth B, Billich A, Datema R, Donatsch P, Hammerschmid F, Harrison R, Hiestand 
P, Jaksche H, Mayer P, Peichl P, et al. 1994. Inhibition of human 
immunodeficiency virus type 1 replication by SDZ NIM 811, a 
nonimmunosuppressive cyclosporine analog. Antimicrob Agents Chemother 
38(8):1763-1772. 
Saatman KE, Creed J, Raghupathi R. 2010. Calpain as a therapeutic target in traumatic 
brain injury. Neurotherapeutics 7(1):31-42. 
Saljo A, Arrhen F, Bolouri H, Mayorga M, Hamberger A. 2008. Neuropathology and 
pressure in the pig brain resulting from low-impulse noise exposure. Journal of 
neurotrauma 25(12):1397-1406. 
Saljo A, Bolouri H, Mayorga M, Svensson B, Hamberger A. 2009a. Low-level blast 
raises intracranial pressure and impairs cognitive function in rats: prophylaxis 
with processed cereal feed. J Neurotrauma 27(2):383-389. 
Saljo A, Svensson B, Mayorga M, Hamberger A, Bolouri H. 2009b. Low-level blasts 
raise intracranial pressure and impair cognitive function in rats. J Neurotrauma 
26(8):1345-1352. 
Saljo A, Svensson B, Mayorga M, Hamberger A, Bolouri H. 2009c. Low levels of blast 
raises intracranial pressure and impairs cognitive function in rats. Journal of 
neurotrauma. 
Sauerbeck A, Pandya J, Singh I, Bittman K, Readnower R, Bing G, Sullivan P. 2011. 
Analysis of regional brain mitochondrial bioenergetics and susceptibility to 
mitochondrial inhibition utilizing a microplate based system. J Neurosci Methods. 
Scarf AM, Ittner LM, Kassiou M. 2009. The translocator protein (18 kDa): central 
nervous system disease and drug design. J Med Chem 52(3):581-592. 
Scheff SW, Dhillon HS. 2004. Creatine-enhanced diet alters levels of lactate and free 
fatty acids after experimental brain injury. Neurochem Res 29(2):469-479. 
Scheff SW, Sullivan PG. 1999. Cyclosporin A significantly ameliorates cortical damage 
following experimental traumatic brain injury in rodents. J Neurotrauma 
16(9):783-792. 
Scheffler IE. 2008. Mitochondria. Hoboken, N.J.: Wiley-Liss. xviii, 462 p., [412] p. of 
plates p. 
Schneider MD. 2005. Cyclophilin D: knocking on death's door. Sci STKE 
2005(287):pe26. 
Singh IN, Sullivan PG, Deng Y, Mbye LH, Hall ED. 2006. Time course of post-traumatic 
mitochondrial oxidative damage and dysfunction in a mouse model of focal 
118 
 
traumatic brain injury: implications for neuroprotective therapy. J Cereb Blood 
Flow Metab 26(11):1407-1418. 
Singleton RH, Yan HQ, Fellows-Mayle W, Dixon CE. 2010. Resveratrol attenuates 
behavioral impairments and reduces cortical and hippocampal loss in a rat 
controlled cortical impact model of traumatic brain injury. J Neurotrauma 
27(6):1091-1099. 
Smith DH, Meaney DF, Shull WH. 2003. Diffuse axonal injury in head trauma. J Head 
Trauma Rehabil 18(4):307-316. 
Starkov AA, Chinopoulos C, Fiskum G. 2004. Mitochondrial calcium and oxidative 
stress as mediators of ischemic brain injury. Cell Calcium 36(3-4):257-264. 
Stoica BA, Faden AI. 2010. Cell death mechanisms and modulation in traumatic brain 
injury. Neurotherapeutics 7(1):3-12. 
Sullivan PG, Brown MR. 2005. Mitochondrial aging and dysfunction in Alzheimer's 
disease. Prog Neuropsychopharmacol Biol Psychiatry 29(3):407-410. 
Sullivan PG, Dube C, Dorenbos K, Steward O, Baram TZ. 2003. Mitochondrial 
uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. 
Ann Neurol 53(6):711-717. 
Sullivan PG, Geiger JD, Mattson MP, Scheff SW. 2000a. Dietary supplement creatine 
protects against traumatic brain injury. Ann Neurol 48(5):723-729. 
Sullivan PG, Keller JN, Bussen WL, Scheff SW. 2002. Cytochrome c release and caspase 
activation after traumatic brain injury. Brain Res 949(1-2):88-96. 
Sullivan PG, Keller JN, Mattson MP, Scheff SW. 1998. Traumatic brain injury alters 
synaptic homeostasis: implications for impaired mitochondrial and transport 
function. J Neurotrauma 15(10):789-798. 
Sullivan PG, Rabchevsky AG, Hicks RR, Gibson TR, Fletcher-Turner A, Scheff SW. 
2000b. Dose-response curve and optimal dosing regimen of cyclosporin A after 
traumatic brain injury in rats. Neuroscience 101(2):289-295. 
Sullivan PG, Rabchevsky AG, Waldmeier PC, Springer JE. 2005. Mitochondrial 
permeability transition in CNS trauma: cause or effect of neuronal cell death? J 
Neurosci Res 79(1-2):231-239. 
Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. 2004. The 
ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann 
Neurol 55(4):576-580. 
Sullivan PG, Sebastian AH, Hall ED. 2011. Therapeutic window analysis of the 
neuroprotective effects of cyclosporine a after traumatic brain injury. J 
Neurotrauma 28(2):311-318. 
Sullivan PG, Thompson M, Scheff SW. 2000c. Continuous infusion of cyclosporin A 
postinjury significantly ameliorates cortical damage following traumatic brain 
injury. Exp Neurol 161(2):631-637. 
Sullivan PG, Thompson MB, Scheff SW. 1999. Cyclosporin A attenuates acute 
mitochondrial dysfunction following traumatic brain injury. Exp Neurol 
160(1):226-234. 
Svetlov SI, Larner SF, Kirk DR, Atkinson J, Hayes RL, Wang KK. 2009. Biomarkers of 
blast-induced neurotrauma: profiling molecular and cellular mechanisms of blast 
brain injury. J Neurotrauma 26(6):913-921. 
119 
 
Taber KH, Warden DL, Hurley RA. 2006. Blast-related traumatic brain injury: what is 
known? J Neuropsychiatry Clin Neurosci 18(2):141-145. 
Tanno H, Nockels RP, Pitts LH, Noble LJ. 1992. Breakdown of the blood-brain barrier 
after fluid percussive brain injury in the rat. Part 1: Distribution and time course 
of protein extravasation. J Neurotrauma 9(1):21-32. 
Thurman DJ, Branche CM, Sniezek JE. 1998. The epidemiology of sports-related 
traumatic brain injuries in the United States: recent developments. J Head Trauma 
Rehabil 13(2):1-8. 
Trudeau DL, Anderson J, Hansen LM, Shagalov DN, Schmoller J, Nugent S, Barton S. 
1998. Findings of mild traumatic brain injury in combat veterans with PTSD and 
a history of blast concussion. J Neuropsychiatry Clin Neurosci 10(3):308-313. 
Unterberg AW, Stover J, Kress B, Kiening KL. 2004. Edema and brain trauma. 
Neuroscience 129(4):1021-1029. 
Vink R, Nimmo AJ, Cernak I. 2001. An overview of new and novel pharmacotherapies 
for use in traumatic brain injury. Clin Exp Pharmacol Physiol 28(11):919-921. 
Votyakova TV, Reynolds IJ. 2005. Ca2+-induced permeabilization promotes free radical 
release from rat brain mitochondria with partially inhibited complex I. J 
Neurochem 93(3):526-537. 
Waldmeier PC, Feldtrauer JJ, Qian T, Lemasters JJ. 2002. Inhibition of the mitochondrial 
permeability transition by the nonimmunosuppressive cyclosporin derivative 
NIM811. Mol Pharmacol 62(1):22-29. 
Walker M. 2007. Neuroprotection in epilepsy. Epilepsia 48 Suppl 8:66-68. 
Wang X, Carlsson Y, Basso E, Zhu C, Rousset CI, Rasola A, Johansson BR, Blomgren 
K, Mallard C, Bernardi P, Forte MA, Hagberg H. 2009. Developmental shift of 
cyclophilin D contribution to hypoxic-ischemic brain injury. J Neurosci 
29(8):2588-2596. 
Weber JT. 2007. Experimental models of repetitive brain injuries. Progress in brain 
research 161:253-261. 
Wehage E, Eisfeld J, Heiner I, Jungling E, Zitt C, Luckhoff A. 2002. Activation of the 
cation channel long transient receptor potential channel 2 (LTRPC2) by hydrogen 
peroxide. A splice variant reveals a mode of activation independent of ADP-
ribose. J Biol Chem 277(26):23150-23156. 
Whalen MJ, Carlos TM, Wisniewski SR, Clark RS, Mellick JA, Marion DW, Kochanek 
PM. 2000. Effect of neutropenia and granulocyte colony stimulating factor-
induced neutrophilia on blood-brain barrier permeability and brain edema after 
traumatic brain injury in rats. Crit Care Med 28(11):3710-3717. 
Woodcock T. 2009. Modulation of the alpa-7 nicotinic acetylcholine receptor following 
experimental rat brain injury improves cellular and behavorial outcomes 
[Doctoral]. Lexington: University of Kentucky. 
Xiong Y, Gu Q, Peterson PL, Muizelaar JP, Lee CP. 1997. Mitochondrial dysfunction 
and calcium perturbation induced by traumatic brain injury. J Neurotrauma 
14(1):23-34. 
Xiong Y, Rabchevsky AG, Hall ED. 2007. Role of peroxynitrite in secondary oxidative 
damage after spinal cord injury. J Neurochem 100(3):639-649. 
120 
 
Yi JH, Hazell AS. 2006. Excitotoxic mechanisms and the role of astrocytic glutamate 
transporters in traumatic brain injury. Neurochemistry international 48(5):394-
403. 
Yoshimoto T, Siesjo BK. 1999. Posttreatment with the immunosuppressant cyclosporin 
A in transient focal ischemia. Brain Res 839(2):283-291. 
Zick M, Rabl R, Reichert AS. 2009. Cristae formation-linking ultrastructure and function 
of mitochondria. Biochim Biophys Acta 1793(1):5-19. 
Zoratti M, Szabo I. 1995. The mitochondrial permeability transition. Biochim Biophys 
Acta 1241(2):139-176. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
121 
 
VITA 
Ryan Douglas Readnower 
Personal Information 
Date of birth: 11-19-1983 
Place of birth: Lexington, KY 
 
Education 
Doctorate of Philosophy, Anatomy and Neurobiology 
 University of Kentucky, Lexington, KY, USA (expected-August 2011) 
B.S., Agricultural Biotechnology with a double major in biology 
 University of Kentucky, Lexington, KY, USA (May 2006) 
 
Professional Positions 
Research Assistant/Doctoral Candidate; June 2006 to July 2011 
 University of Kentucky, Lexington, KY 
Teacher Assistant-Anatomy & Physiology for Nursing; August 2008-May 2009 
 University of Kentucky, Lexington, KY 
 
Publications 
RD Readnower, JD Pandya, ML McEwen, JR Pauly, JE Springer, PG Sullivan. (2011) 
Post-injury administration of the mitochondrial permeability transition pore inhibitor, 
NIM811, is neuroprotective and improves cognition following traumatic brain injury in 
rats. Journal of Neurotrauma, accepted. 
RD Readnower, AD Sauerbeck, PG Sullivan. (2011) Mitochondria, Amyloid-β, and 
Alzheimer’s Disease. Invited review-International Journal of Alzheimer’s Disease (PMID 
21547208). 
A Sauerbeck, J Gao, R Readnower, M Liu, JR Pauly, G Bing, PG Sullivan. (2011) 
Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue 
122 
 
loss, and inflammation following traumatic brain injury. Experimental Neurology, 277, 
128-135 (PMID 20965168). 
A Sauerbeck, J Pandya, I Singh, K Bittman, R Readnower, G Bing, PG Sullivan. 
(2011)Analysis of regional brain mitochondrial bioenergetics and susceptibility to 
mitochondrial inhibition utilizing a microplate based system. Journal of Neuroscience 
Methods, 227, 128-135  (PMID 21402103).   
RD Readnower, LM Davis, PG Sullivan. (2011) Neuroprotective Strategies and Targets 
of Intervention in Epilepsy. Epilepsy-Book 5. Intech.  
PG Sullivan, RD Readnower. (2010) Chapter 11: Neuroprotective Strategies Using 
Antiepileptic Drugs (Pgs 173-180).  Epilepsy: Mechanisms, Models, and Translational 
Perspectives. CRC Press.  
RD Readnower, M Chavko, S Adeeb, MD Conroy, JR Pauly, RM McCarron, PG 
Sullivan. (2010) Increase in blood–brain barrier permeability, oxidative stress, and 
activated microglia in a rat model of blast-induced traumatic brain injury. Journal of 
Neuroscience Research, 88, 3530-3539 (PMID 20882564). 
LM Davis, JR Pauly, RD Readnower, JM Rho, PG Sullivan. (2008) Fasting is 
neuroprotective following traumatic brain injury. Journal of Neuroscience Research, 86, 
1812-1822 (PMID 18241053). 
 
Abstracts 
R Readnower, J Geddes, P Sullivan. Genetic analysis of the role of cyclophilin D in 
traumatic brain injury pathology. National Neurotrauma Symposium; July 2011, P245.  
R Readnower, J Pandya, P Sullivan. A novel, nano-scaled device to increase metabolism 
via mitochondrial uncoupling. May 2011, Poster presentation at the Barnstable Brown 
Obesity and Research Day.  
RD Readnower, JW Geddes, JR Pauly, PG Sullivan. Cyclophlin D as a therapeutic 
target following traumatic brain Injury. May 2011, Poster presentation at the 17th Annual 
Kentucky and Spinal Cord and Head Injury Research Trust Symposium.  
R Readnower, J Geddes, P Sullivan. The efficacy of NIM811, a nonimmunosupressive 
cyclosporin A analog, following experimental traumatic brain injury. Journal of 
Neurotrauma Abstracts; May 2010, A-231. 
A Sauerbeck, P Sullivan, R Readnower, G Bing, J Gao. Therapeutic efficacy of 
pioglitazone following traumatic brain injury. Journal of Neurotrauma Abstracts; May 
2010, A-66.  
123 
 
RD Readnower, R McCarron, M Chavko, S Adeeb, P Sullivan. Blast induced 
neurotrauma in the rat brain. Journal of Neurotrauma Abstracts; August 2009, A-87. 
RD Readnower, M Chavko, R McCarron, P Sullivan. Neurotrauma in the rat brain 
caused by blast overpressure. June 2009, poster presentation at the 15th annual Kentucky 
and Spinal Cord and Head Injury Research Trust Symposium. 
RD Readnower, R McCarron, M Chavko, P Sullivan. Blast induced traumatic brain 
injury: characterizing the injury pathology. Journal of Neurotrauma Abstracts; July 2008, 
Vol. 25, No. 7: 904. 
RD Readnower, AH Sebastian, LM Davis, GA Goldstein, PG Sullivan. Following 
traumatic brain injury antioxidant therapy, TOVA (a glutathione precursor), increases 
tissue sparing and reduces oxidative stress. June 2008, poster Presentation at the 14th 
Annual Kentucky Spinal Cord and Head Injury Research Trust Symposium. 
LM David, JR Pauly, AH Sebastian, RD Readnower, JM Rho, PG Sullivan. Acute post 
injury fasting is neuroprotective following traumatic brain injury: potential mechanisms 
and implications for treatment. November 2007, Poster presentation at the Society for 
Neuroscience annual meeting. 
LM Davis, AH Sebastian, RD Readnower, JM Rho, PG Sullivan. Acute post injury 
fasting is neuroprotective following traumatic brain injury; potential mechanisms and 
implications for treatment. Journal of Neurotrauma Abstracts; July 2007, Vol. 24, No. 7: 
1270. 
RD Readnower, AH Sebastian, LM Davis, GA Goldstein, PG Sullivan. Administration 
of a novel, cell-permeant glutathione precursor, TOVA, following traumatic brain injury 
increases tissue sparing and reduces oxidative stress. Journal of Neurotrauma Abstracts; 
July 2007, Vol. 24, No. 7: 1243. 
